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  ABSTRACT 
The anthocyanins show efficient antioxidant properties and free radical scavenging 
properties which result in various health-promoting benefits. This research investigated 
the ability of anthocyanidins to distribute into mitochondria and protect mitochondria 
from oxidative stress.  
In an in vitro study, the uptake of pure cyanidin and quercetin, and their 3-
glucosylated forms into isolated rat liver mitochondria was tested, along with their 
effects on mitochondrial oxidative stress parameters. The absorption of cyanidin was 
significantly higher (67% uptake of 125 µM) than the other three flavonoids. 
Measurements indicated that the cyanidin was taken up into or tightly bound by 
mitochondria. Also, results suggested that cyanidin uptake was partially dependent on 
membrane potential. When incubated together (internally and externally) with 
mitochondria all tested flavonoids decreased reactive oxygen species (ROS) generation 
during mitochondrial respiration, and inhibited lipid peroxidation to different extents. 
Importantly, pre-loaded CY showed much stronger effects against oxidative stress in 
two analyses than other flavonoids. Due to its greater uptake by mitochondria, cyanidin 
may provide greater protection in vivo.  
In an in vivo study, cyanidin, quercetin and their 3-glucosides were administered 
into rat tail vein to give a dose of 7.6 µmol/Kg body weight. Cyanidin and its glucoside 
had greater affinity to liver and kidney than did quercetin and its glucoside; 
particularly, all test tissues contained a significantly higher amount of cyanidin than 
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other test flavonoids. Also, cyanidin accumulated more in liver mitochondria than other 
flavonoids, and consistent with in vitro results was present in mitochondria to a much 
greater extent than cyanidin glucoside. However, delivery of the flavonoids at this dose 
did not significantly affect the liver mitochondria susceptibility to lipid peroxidation or 
the level of endogenous tissue oxidative damage. 
Altogether the results show that cyanidin can rapidly and efficiently accumulate in 
mitochondria, wherein it exhibits strong bio-antioxidant activity against oxidative stress 
and may help protect mitochondrial function and integrity. Also, the anthocyanidin and 
its 3-glucoside have greater ability than flavonols to accumulate in organs; especially 
cyanidin presented in liver mitochondria to a much greater extent. Cyanidin could be a 
potent natural antioxidant compound that is effective in mitochondria-protective 
therapies. 
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1. INTRODUCTION 
1.1 Mitochondria in health and disease  
There is substantial evidence that mitochondria-derived reactive oxygen species 
(ROS) cause oxidative damage to biological macromolecules and contribute to aging 
and a range of human diseases including cancer, diabetes, obesity, stroke, and 
neurodegenerative diseases (Armstrong, 2008; Davidson, 2010; de Moura et al., 2010; 
Harman, 1972; Ladiges et al., 2010; Witte et al., 2010). The mitochondrial respiratory 
chain is considered as a major source of ROS, which increase with age (Bandy & 
Davison, 1999; Ladiges et al., 2010; Witte et al., 2010).  
Excess production of ROS results in significant oxidative stress in the 
mitochondria, can trigger mitochondrial dysfunction and cell death, and is implicated in 
ageing and many diseases (Pieczenik & Neustadt, 2007).  It has been demonstrated that 
ROS can increase oxidative damage to lipid and proteins; also, cause damage and high 
mutation rates of mitochondrial DNA (mtDNA) and alterations of the expression of 
several clusters of genes in ageing tissues and senescent cells (Ladiges et al., 2010). 
Preventing mitochondrial damage and reducing the release of active oxygen species 
could efficiently limit age-related oxidative stress and disease. Therefore, antioxidants 
which can directly target and have effect in the mitochondria will most efficiently 
prevent or decrease the oxidative damage (Smith et al., 2008).  
1.2 Protection against oxidative stress and disease by flavonoids and anthocyanins 
Flavonoids have gained considerable attention recently, particularly because of 
their antioxidant and radical-scavenging activities. It has been documented that 
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flavonoids have efficiency against oxidative damage and related diseases (Darvesh et 
al., 2010; Havsteen, 2002). Particularly, anthocyanin-rich red and purple berries have 
attracted considerable interest and extensive mechanistic studies for their potential 
protective effects and health benefits (Andres-Lacueva et al., 2005; Hassimotto et al., 
2008; Neto, 2007; Serraino et al., 2003). The anthocyanins are unique among the 
flavonoids in not being negatively charged at physiological pH, and show efficient 
antioxidant and free radical scavenging properties (Kong et al., 2003). The 
anthocyanins have an array of health-promoting benefits as they can protect against a 
variety of oxidants through several mechanisms.  
Studies have shown that anthocyanins have some beneficial health effects such as 
reducing age-associated oxidative stress, possessing anti-inflammatory properties, 
preventing cancer, and protecting against vascular diseases (Dai et al., 2009; Kong et 
al., 2003; Neto, 2007; Thomasset et al., 2009b). Also, anthocyanins have several 
peripheral effects including: stabilizing connective tissue, promoting collagen 
formation and helping to prevent oxidative damage to blood vessels (Andres-Lacueva 
et al., 2005; Chrubasik et al., 2010). 
The antioxidant activity of anthocyanins and their other functions has been well 
studied in vitro, as well as the correlation between their antioxidant capacity and 
chemical structure (Kong et al., 2003). However, there are still fewer studies as 
compared to studies of other flavonoids. The antioxidant efficacy in vivo of 
anthocyanins has also been less thoroughly documented, possibly due to the limited 
sources of pure anthocyanins and the associated cost. Moreover, information on 
whether they could enter cells and accumulate in subcellular organelles such as 
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mitochondria in the specific tissues and organs and its effects becomes a major 
question. Results from these types of studies will contribute to our understanding of the 
potential significance of anthocyanins in human health.  
Interest in the in vivo bioavailability of anthocyanins arises from evidence 
supporting a role for these flavonoids in human health. Anthocyanins have an affinity 
for, and accumulate in tissues such as kidney and skin (Matsumoto et al., 2006a; 
Matsumoto et al., 2006b). For further discussion on in vivo functions of anthocyanins, 
it is critical to know the physiological uptake and distribution of each anthocyanin in 
tissues and intracellular deposition perhaps especially in mitochondria. 
Studies on the anthocyanin absorption and metabolism in tissues were reported 
elsewhere in both human and experimental animals (Bub et al., 2001; Kalt et al., 2008; 
Matsumoto et al., 2001; Mazza et al., 2002; Miyazawa et al., 1999; Talavéra et al., 
2005) In these studies significant anthocyanin contents were found in ocular, brain, 
kidney and liver tissue, as well as plasma and urine, after either oral or intravenous 
treatment mainly using berry fruits extract as the anthocyanin source (Andres-Lacueva 
et al., 2005; Ichiyanagi et al., 2006; Matsumoto et al., 2006b; Talavéra et al., 2005).     
However, there are no data on the potential ability of anthocyanins to reach and be 
taken up in the mitochondria. As well, such studies using fruit extracts as anthocyanin 
sources are not suitable for precise discussion of anthocyanin metabolism. I thus 
studied the uptake of anthocyanins in isolated mitochondria and distribution in 
experimental animals using pure anthocyanins.  
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2. LITERATURE REVIEW 
2.1 Mitochondria in health and disease 
Mitochondria, as the cell's powerhouse, occupy a unique position in controlling the 
life and death of a cell. Physiologically, mitochondria perform a variety of key cellular 
functions, including ATP production, intracellular Ca2+
DiMauro, 2004
 regulation, reactive oxygen 
species (ROS) generation, and apoptosis ( ; Hoye et al., 2008; Reddy, 
2006; Seddon et al., 2007; Zeviani et al., 1989). Importantly, as the mitochondria play a 
dominant role in processing oxygen and then converting substances from foods into 
ATP that powers most cell functions, if problems happen within the mitochondria, it 
could result in many health problems. Mitochondrial damage and /or dysfunction 
disrupt the function of cells, tissues, and organs and contribute to a remarkably wide 
range of diseases (DiMauro, 2004).  
The mitochondrial respiratory chain (complexes I-V) provides the oxidative 
metabolic pathway in the cell, and its biosynthesis is controlled by the mitochondrial 
genome (mtDNA) and the nuclear genome (nDNA) (Dimauro, 2010). Mutations of 
mitochondrial DNA damage mitochondrial function and lead to a number of 
mitochondrial related diseases. For instance, mitochondrial or nuclear DNA mutation 
can influence the energy production ability of the mitochondria, and consequently 
causes certain types of disease such as MELAS (Mitochondrial Encephalomyopathy) 
and MERRF (Myoclonic Epilepsy with Ragged Red Fibers) (Armstrong, 2007; 
DiMauro, 2004). In these diseases, the mitochondrial defect usually affects the 
muscles, cerebrum, or nerves because these cells require the most energy.  
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As well as diseases directly caused by mitochondrial DNA mutation, mitochondrial 
oxidative damage contributes to the pathology of many other disorders, such as 
cardiovascular and neurodegenerative disease (Armstrong, 2007; DiMauro, 2004, 
2010; Newsholme et al., 2007). 
Although the mitochondrial free radical theory of ageing has recently come into 
question, characteristic decreases in mitochondrial function and increases in oxidative 
stress with age are well documented and accepted (Hekimi et al., 2011; Lapointe & 
Hekimi, 2010; Salmon et al., 2010). In the ageing process a number of changes in 
mitochondria occur, such as respiratory function decline along with a concomitant 
increase in production of reactive oxygen species; in particular, mtNDA mutations and 
oxidative damage are increased in ageing human tissues (Lee & Wei, 2007; Muller-
Hocker, 1992; Wei, 1998; Wei et al., 2001). 
2.2 The concept of oxidative stress and mitochondrial disease 
2.2.1 Reactive oxygen species (ROS)  
Free radicals derived from oxygen represent the most important group of radical 
species generated in living systems (Miller et al., 1990). Normally, oxygen free radicals 
or, more generally, reactive oxygen species (ROS), as well as reactive nitrogen species 
(RNS), are formed during a variety of biochemical reactions and cellular functions 
(Valko et al., 2007). Physiological concentrations are required for normal cell functions 
including intracellular signaling and redox regulation (Nordberg & Arner, 2001). 
However, excessive quantities of ROS can be very harmful to living systems. 
Overproduction of ROS causes oxidative damage, which leads to loss of cell function 
and apoptosis or necrosis (Zamzami et al., 1997). Also, accumulated ROS generation 
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contributes to the physiology of ageing (Halliwell & Gutteridge, 1999; Valko et al., 
2007; Valko et al., 2006) .  
Several reactive oxygen species are formed in the human body and include: the 
superoxide radical (O2•-); hydrogen peroxide (H2O2); hypochlorous acid (HOCl); the 
hydroxyl radical (•OH); peroxyl ion (O22-);  hydroperoxyl radical (HO2
Halliwell, 1999
•); lipid peroxyl 
radicals (LOO•); and lipid hydroperoxide (LOOH) (Groff & Gropper, 2000). ROS can 
readily react with most biomolecules, and start a chain reaction of free radical 
formation. In order to stop this chain reaction and further consequent damage, the 
formed radical must either react with another free radical, eliminating the unpaired 
electrons, or react with a free radical scavenger— a chain-breaking or primary 
antioxidant ( ; Nordberg & Arner, 2001).  
2.2.2 Oxidative stress contributes to the development and pathology of many 
human diseases  
Oxidative stress is a state where excess ROS overpower endogenous antioxidant 
systems and cause damage to all components of the cell, including proteins, lipids, and 
DNA. Such damage triggers cell dysfunction and death; and consequently it applies in 
various disease states and ageing (Valko et al., 2007).  
Oxidative stress has been associated with numerous human diseases including 
Alzheimer’s, amyotrophic lateral sclerosis (ALS), Parkinson’s, atherosclerosis, 
ischemia/reperfusion neuronal injuries, degenerative disease of the human 
temporomandibular joint, cataract formation, macular degeneration, degenerative 
retinal damage, rheumatoid arthritis, multiple sclerosis, muscular dystrophy, and 
cancers (Christen, 2000; Davi et al., 2005; Hitchon & El-Gabalawy, 2004; Milam et al., 
1998; Nunomura et al., 2006; Rando et al., 1998; Varma et al., 1995; Wood-Kaczmar et 
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al., 2006). A good example is how oxidative stress has an effect in cardiovascular 
disease. Studies document that oxidation of low density lipoprotein (LDL) initially 
drives the atherogenesis process, which leads to atherosclerosis formation, and finally 
results in cardiovascular diseases (Aviram, 2000; Van Gaal et al., 2006). In addition, 
lipid peroxidation occurs at the biological tissues even in healthy organisms, and 
contributes to ageing and oxidative stress related disease (Halliwell & Chirico, 1993; 
Negre-Salvayre et al., 2010).  
2.2.3 Oxidative damage in mitochondria 
2.2.3.1 Mitochondria are a major source of ROS generation  
 ROS are generated within the cell and within mitochondria through endogenous 
enzymatic and non-enzymatic reactions (Finkel & Holbrook, 2000). Mitochondrial 
sources include the electron transport chain which passes electrons from the electron 
carriers through the respiratory chain to oxygen, and monoamine oxidase (MAO) at the 
outer membrane. Cytosolic sources of ROS are xanthine oxidase (XO) and cytochrome 
P450 reductases. Plasma membrane-linked sources of ROS include the NADPH 
oxidases and cytochrome P450 (Armstrong, 2008; Halliwell, 2006). ROS can also arise 
outside the cell, including singlet oxygen (1O2) generation by UV irradiation, 
environmental ozone (O3
Victor & Rocha, 2007
) or other ROS and RNS in pollutants, such as cigarette smoke 
( ).  
The most important source of ROS under normal conditions in aerobic organisms is 
the leakage of activated oxygen from mitochondria, which carry out oxidation reactions 
during normal oxidative respiration (Halliwell, 2001). Indeed, much experimental 
evidence strongly suggests that leakage of electrons from the electron transport chain, 
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located in the inner mitochondrial membrane, is a major source of ROS in living cells 
((Bandy & Davison, 1990; Peterside et al., 2003). The details of ROS species 
generation in mitochondria are well discussed in several papers (Cadenas & Davies, 
2000; DiMauro, 2004; Halliwell, 2006; Halliwell & Gutteridge, 1999; Murphy, 2009; 
Murphy & Smith, 2007; Valko et al., 2007). 
Superoxide anion (O2•-
Cadenas & Sies, 1998
), considered the “primary” ROS, is generated mostly within 
the mitochondrial complexes I and III ( ; Valko et al., 2007). O2•-
 can be subsequently converted to other reactive species, including hydrogen peroxide 
(H2O2
Raha & Robinson, 2000
), which can further react to form the highly reactive hydroxyl radical (•OH ) via 
the Fenton reaction ( ; Valko et al., 2007). Hydroxyl radical has 
strong reactivity with biomolecules, and is considered more dangerous to biological 
systems than any other ROS (Nordberg & Arner, 2001). Importantly, the strong 
oxidants including peroxyl radicals (ROO•) derived from these toxic electron transport 
chain reactions initiate fatty acid peroxidation.  
2.2.3.2 Mitochondria are susceptible to oxidative damage 
Mitochondria are considered the most important source of ROS production in 
mammalian organs under normal conditions (Cadenas & Davies, 2000; Kowaltowski & 
Vercesi, 1999; Skulachev, 1996), making mitochondria especially vulnerable to 
oxidative damage. Mitochondrial components are exposed to a relatively high amount 
of ROS. Evidence indicates that, in vitro, mitochondria convert 1–2% of the oxygen 
molecules consumed into superoxide anions at intermediate steps of the mitochondrial 
respiratory chain (Kowaltowski & Vercesi, 1999; Skulachev, 1996).  Also, it has been 
shown that the steady state concentration of O2•- in the mitochondrial matrix is about 5- 
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to 10-fold higher than that in the cytosolic and nuclear spaces (Cadenas & Davies, 
2000). 
ROS can result in significant damage to mitochondrial components and initiate 
degradative processes. Consequences of this damage include modification to proteins, 
lipids and DNA, which thereby disrupt mitochondrial function and also cause more 
ROS to be released to the cytosol (Murphy & Smith, 2007; Pieczenik & Neustadt, 
2007). 
2.2.3.3 Oxidative damage to mitochondrial DNA, protein and lipid. 
Mitochondrial DNA (mtDNA) is a more sensitive target for oxygen radical attack 
than nuclear DNA (nDNA) (Cadenas & Davies, 2000; Richter et al., 1988). mtDNA 
damage can lead to dysfunction of the mitochondrial respiratory chain, which further 
stimulates the overproduction of ROS and additional mtDNA damage ((Bandy & 
Davison, 1990), and consequently apoptosis may occur (Ozawa, 1997).  Indeed, 
mtDNA fragmentation is associated with ageing (Muller-Hocker, 1992; Ozawa, 1998).  
Mitochondrial ROS interact directly with a wide variety of mitochondrial proteins, 
and cause mitochondrial protein regulatory and pathological dysfunction (Page et al., 
2010). Mitochondrial enzyme proteins are essentially all susceptible to attack by ROS 
(Kowaltowski & Vercesi, 1999; Raha & Robinson, 2000). Studies have demonstrated 
that O2•-, H2O2
Newsholme et al., 2007
 and •OH inhibit enzyme activities in different regions of the electron 
transport chain. NADH dehydrogenase, succinate dehydrogenase, and ATPase 
activities are rapidly damaged by the above mentioned ROS ( ; 
Zhang et al., 1990).  
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In addition, in the presence of Ca2+
Kowaltowski & Vercesi, 1999
, the oxidation of membrane protein thiols causes 
inner membrane permeabilization, which is referred to as the mitochondrial 
permeability transition (MPT) ( ). MPT involves MPT 
pores opening, and leads to more ROS generation, and mitochondrial swelling, which 
triggers cell death in the intrinsic pathway of apoptosis (Fiskum, 2000). MPT allows 
Ca2+ Brookes et al., 
2004
 to leave the mitochondrion, which causes further stress in the cell (
). 
Lipid peroxidation results in major oxidative damage to biological membranes 
(Halliwell & Chirico, 1993). Oxidation of fatty acids can cause membrane alterations 
(even in healthy organisms), increased membrane fluidity and permeability, efflux of 
cytosolic solutes and loss of membrane protein activities under oxidative stress (Avery, 
2011). Mitochondrial generated ROS not only could attack DNA and protein, but also 
polyunsaturated fatty acids present in the mitochondrial membrane.  
Mitochondrial membrane lipid peroxidation significantly damage mitochondrial 
respiration, oxidative phosphorylation and ion transport functions (Kowaltowski & 
Vercesi, 1999; Pieczenik & Neustadt, 2007). Importantly, lipid peroxidation damage 
complex I and induces MTP (Murphy & Smith, 2007). Also, ROS can degrade 
polyunsaturated lipids to form the highly reactive compound malondialdehyde (MDA), 
which reacts with the DNA building blocks, deoxyguanosine and deoxyadenosine so as 
to form DNA adducts, which contribute significantly to the risk of cancer (Davi et al., 
2005; Kowaltowski & Vercesi, 1999; Marnett, 1999).  
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Moreover, oxidative damage could increase the tendency of mitochondria to release 
intermembrane space proteins such as cytochrome c to the cytosol, and thereby activate 
cell apoptosis (Zamzami et al., 1997).  
2.2.3.4 Oxidative damage cause mitochondrial diseases 
Significantly, mitochondrial mutations and dysfunction caused by oxidative damage 
trigger necrosis and apoptosis of cells and are implicated in a number of diseases 
((Bandy & Davison, 1990; DiMauro, 2004; Zamzami et al., 1997). For example, liver 
failure is often associated with mitochondrial DNA (mtDNA) depletion syndromes 
(Dubern et al., 2001).  It is a vicious cycle among oxidative stress and mitochondrial 
dysfunction.  As oxidative stress occurs, it causes mitochondrial DNA mutations, 
protein modifications, enzymatic abnormalities and lipid peroxidation, which in turn 
fuels oxidative damage; consequently resulting in mitochondrial dysfunction and cell 
death. There is remarkable realization that impairments of mitochondria caused by 
acute and chronic oxidative stress are the key component of mitochondria disease 
etiology (Sheu et al., 2006). 
Indeed, it has been suggested that generation of oxidants by mitochondria, and 
damage of mitochondrial components and functions, are important aspects of the 
ageing process (Ashok & Ali, 1999) . In nearly all diseases caused by mitochondrial 
dysfunction, ROS metabolism is one of the crucial factors (DiMauro, 2004, 2010).As 
mitochondrial damage leads to significant health risk, a therapy to decrease oxidative 
damage would be useful in a range of clinical situations. Prevention of mitochondrial 
damage and reduction in the release of ROS could efficiently limit mitochondria-
related diseases and ageing. Antioxidants which can target and have effect in the 
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mitochondria will most efficiently prevent or decrease the oxidative damage in 
mitochondria; a continued search for better and more effective antioxidants to prevent 
or decrease mitochondrial damage is needed. 
2.3 Antioxidants against oxidative stress 
The complex interplay between free radicals and intracellular antioxidant systems is 
very important for cell functions and living systems. As oxidative stress is considered 
to be an important part of many diseases, many types of antioxidants are available for 
use in foods and in dietary supplements for the prevention of disease or as 
pharmacological treatments. 
2.3.1 Physiological defense mechanisms and antioxidants 
Antioxidant enzymes and low molecular weight antioxidants are two components 
that compose the antioxidant defense system in cells. Antioxidant enzymes include 
superoxide dismutase (SOD), catalase (CAT), thioredoxin and glutathione peroxidase 
(GPx); and the low molecular weight antioxidants include vitamins A and E, ascorbic 
acid (vitamin C), and glutathione (GSH) as well as many natural compounds such as 
polyphenols (Juurlink & Paterson, 1998; Nordberg & Arner, 2001; Valko et al., 2007). 
These substances are the body's natural defense against endogenously generated ROS 
and other free radicals. Their protective abilities against oxidative stress have been 
reported in numerous reviews and original papers (Avery, 2011; Fridovich, 1995; 
Halliwell, 1999, 2006; Valko et al., 2007). The human diet also contains many 
compounds of antioxidant nature, such as polyphenols; especially flavonoids, which 
have gained considerable attention, particularly because of their antioxidant and 
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radical-scavenging activities (Heim et al., 2002; Krishnaswamy & Raghuramulu, 
1998).       
2.3.2 Theory of mitochondria targeting  
Given the mitochondrion’s essential role in a wide range of human disease, a need 
exists to choose efficient antioxidants that protect mitochondrial functions. However, 
the administration of antioxidants has failed to show consistent and significant benefits 
in mitochondrially related diseases (Halliwell, 2011; Sheu et al., 2006). For example, 
vitamin E administration has showed no benefits in the treatment of Parkinson’s 
diseases (The Parkinson Study Group, 1993, 1998).  
The most reasonable explanation for antioxidants inefficacy is their limited 
bioavailability and/or distribution into the mitochondria (Fink et al., 2009; Halliwell, 
2001; James et al., 2007; Sheu et al., 2006). Increasing the antioxidant capacity of the 
mitochondrial is a potential therapy against oxidative damage (Smith et al., 2003).  
Nowadays, targeted antioxidants have been developed by conjugating the lipophilic 
triphenylphosphonium (TPP) cation (Figure 2.1) to an antioxidant moiety, such as the 
mitochondria-targeted derivative of ubiquinone (MitoQ) or the mitochondria-targeted 
derivative of α-tocopherol (MitoVit E) (Milagros Rocha & Victor, 2007; Sheu et al., 
2006). These compounds pass easily through all biological membranes, accumulate in 
the cell, and further into the mitochondria due to the plasmalemmal and mitochondrial 
membrane potentials (Sheu et al., 2006; Smith et al., 1999). These compounds have 
yielded remarkable experimental results in mitochondria studies, and cells and tissues 
undergoing oxidative stress and apoptotic death (Dhanasekaran et al., 2004; Smith et 
al., 2008; Victor & Rocha, 2007).  
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Figure 2.1 TPP+ cation  X is a conjugated antioxidant moiety. 
 
In order to exhibit mitochondrial targeting, the two major structural features of 
compounds are: a sufficient hydrophobic surface; and a positive charge.  These two 
features allow direct permeation of the mitochondrial membranes so that substantial 
concentrations of the selected compounds within the mitochondria can occur (Ross et 
al., 2005).  
In principle, any antioxidant with a lipophilic cation structure could be used for 
targeted delivery to the mitochondria (Armstrong, 2008). Anthoycanins would fit this 
model as they have similar structural features with the TPP cation in that they are 
aromatic, somewhat hydrophobic, and possess a positive charge (at specific pH 
conditions). Based on these structural features and their good antioxidant properties, I 
investigated both mitrochondrial uptake and potential protection against oxidative 
stress of a select group of flavonoids.  
2.4 Flavonoids 
2.4.1 Overview 
The aim of this section is to demonstrate that flavonoids; and specifically 
anthocyanidins, should be of great practical use against mitochondrial oxidative stress.  
Flavonoids are a class of secondary plant polyphenolics with significant antioxidant 
and metal-chelating properties (Potter & Steinmetz, 1996).  Flavonoids cannot be 
P+ X
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synthesized by humans or other animals (Obrenovich et al., 2010).  They are most 
concentrated in fruits, vegetables, nuts, spices, herbs, seeds, wines, teas and cocoa, and 
are consumed regularly in the human diet (Heim et al., 2002). With more developed 
analyses, flavonoids consumption for several countries had been estimated to total 
range from about 20 mg/day to 70 mg/day more recently(Beecher, 2003).  
Numerous studies have strongly suggested that flavonoids exhibit health benefits 
including antioxidant, anticarcinogenic, antimutagenic, antiallergic, and anti-
inflammatory properties, and pharmacological effects such as antituberculosis, 
antimalarial, antimicrobial and antiviral (Darvesh et al., 2010; Havsteen, 2002; Hu et 
al., 2006; Middleton et al., 2000). Indeed, a flavonoid rich diet has been linked with 
lower risk of heart disease and cancer (Knoops et al., 2004). The attention on the 
possible health benefits of flavonoids has risen quickly, mostly because of their potent 
antioxidant abilities and free-radical scavenging activities (Obrenovich et al., 2010)   
Epidemiological studies provide insight that flavonoid-rich foods are associated with 
decreased chronic diseases such as cardiovascular disease, cancer, stroke, and even 
may have an effect on ageing (Bazzano et al., 2003; Dauchet & Dallongeville, 2008; 
Eichholzer et al., 2001; Mink et al., 2007).  
A decreased risk coronary heart disease (CHD) mortality was strongly and inversely 
associated with flavonol and flavone intake in the Zutphen Elderly Study where more 
than a 50% reduction in mortality risk was found (Hertog et al., 1993). A 10-year 
follow-up of the same group found that a high flavonoid intake was correlated with a 
lower incidence of coronary disease (Hertog et al., 1997).  Similar findings were shown 
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in a cohort study of 5,133 Finnish men and women where increasing flavonoid intake 
reduced CHD mortality (Knekt et al., 1996). 
Additionally, flavonoid intake showed a noticeable reduction in the risk of cancer 
and type 2 diabetes (Zunino, 2009).  A case-control study from Spain showed that total 
flavonoid intake was inversely associated with gastric cancer (Garcia-Closas et al., 
1999).   
2.4.2 Structure/Subclasses  
Over 6400 natural flavonoids have been characterized from various plants. 
Flavonoids are classified according to their chemical structure, and are usually 
subdivided into the subgroups shown in Table 2.1. The basic structure of a flavonoid 
(Figure 2.2) is comprised of two benzene rings (A and B), which are linked through a 
heterocyclic pyran or pyrone (with a double bond) ring (C).  
  
Figure 2.2 Basic flavonoid structure. 
Flavonoids can be further subdivided into eight major subclasses based upon 
variations in the heterocyclic C-ring (Beecher, 2003). There are six major subclasses 
(Table 2.1) including flavones, flavonols, flavanones, catechins, anthocyanidins, and 
isoflavones; as well as two minor ones, the dihydroflavonols and chalcones (Heim et 
al., 2002; Peluso, 2006).  
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Table 2.1 Major flavonoid subclasses, chemical characteristics, and typical food 
sources. (Beecher, 2003)      
Flavonoid 
subclass 
B-ring 
position 
to C-ring 
C-ring 
unsaturation 
C-ring 
functional 
groups 
Food flavonoids Major food sources 
Flavanol 2 None 3-hydroxy 
Catechins  
Epicatechins  
Epigallocatechin 
Teas, red 
grapes and 
red wines 
Flavanones 2 None 4-oxo Eriodictyol  Hesperetin Naringenin Citrus foods 
Flavones 2 2-3 double bond 4-oxo 
Apigenin  
Luteolin  
Tangeritin 
Green leafy 
spices 
Isoflavones 3 2-3 double bond 4-oxo 
Biochanin A  
Coumestrol  
Daidzein  
Daidzin Genistein  
Soy beans, 
soy food, 
legumes 
Flavonols 2 2-3 double bond 3-hydroxy,  4-oxo 
Kaempferol  
Myricetin  
Pachypodol  
Quercetin 
Apple, 
onions, 
berries, 
citrus fruits   
Anthocyanidins 2 1-2, 3-4 double bounds 3-hydroxy 
Cyanidin  
Delphinidin 
 Malvidin  
Pelargonidin  
Red, purple 
and blue 
grapes and 
berries 
 
Most dietary flavonoids occur in food as water-soluble O-glycosides, in which 
carbohydrate moieties attach to one or more hydroxyl groups; and with smaller 
amounts of more hydrophobic aglycones (Peluso, 2006). Attached carbohydrate 
moieties include D-glucose, L-rhamnose, D-glucorhamnose, D-galactose, lignin, and 
D-arabinose (Heim et al., 2002).     
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Figure 2.3 Structures of some common flavonoids.  
 
2.4.3 Absorption and bioavailability 
The nutritional and or/medicinal potential of flavonoids can be affected by limited 
systemic and target tissue bioavailability and rapid metabolism (Obrenovich et al., 
2010).  For a better understanding of the important effects of flavonoids in human 
health and disease, a number of literature reviews of flavonoids metabolism and 
disposition are available (Griffiths, 1982; Hackett, 1986; Hollman & Katan, 1998). 
The degree of absorption of individual flavonoid subclasses are different, and 
depend on several factors such as, chemical structure and location of absorption (Heim 
et al., 2002; Tapiero et al., 2002). It has been established that flavonoids enter the 
gastrointestinal tract, and absorption processes occur in the small intestine and colon 
(Scalbert & Williamson, 2000). Generally, flavonoid glycosides have to be 
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enzymatically deglycosylated prior to absorption and further metabolized by the liver; 
whereas aglycones are absorbed directly from the small intestine and then secreted in 
bile and urine (Griffiths, 1982; Hollman & Katan, 1997). However, some evidence 
suggests that anthocyanin glycosides are absorbed intact (Cao & Prior, 1999; 
Matsumoto et al., 2001). 
Also, the presence of carbohydrate residues affects the physicochemical properties 
of the molecule and thus their ability to cross membranes and enter cells (Hollman & 
Katan, 1999). In addition, isoflavones have the highest bioavailability followed by 
flavanols, flavanones and flavonol glycosides (Passamonti et al., 2009).   
Animal and human trials provide sufficient evidence that flavonoids are rapidly 
absorbed in the body and distributed in the tissues (Ali et al., 2005; de Boer et al., 
2005; Kalt et al., 2008; Matsumoto et al., 2006a; Rein et al., 2000; Reinboth et al., 
2010). Also in human studies, experiments showed the relative increased 
concentrations of anthocyanins present in plasma, serum and urine after administration 
(Cao & Prior, 1999; Matsumoto et al., 2001; Mazza et al., 2002; McGhie et al., 2003). 
Still, the exact mechanism of flavonoid absorption and metabolism are unclear. Some 
types of flavonoids have received very limited study and detailed evidence is needed.  
2.4.4. Protection against oxidative stress and disease  
The research on flavonoid health benefits, particularly as it relates to oxidative stress 
has begun more recently as compared to other antioxidants. This section focuses on the 
flavonoid antioxidant ability and related potential benefit in prevention of oxidative 
stress and disease. 
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2.4.4.1 Antioxidant properties against oxidative damage 
Flavonoids help protect against oxidative damage by contributing to the total 
antioxidant defense system along with antioxidant vitamins and enzymes. The 
antioxidant activity of flavonoids is regarded to be related to 1) scavenging free 
radicals, 2) chelating transition-metals involved in free-radical production and 3) 
inhibiting the enzymes participating in free-radical generation (Aruoma, 2003).   
As shown below, flavonoids are able to donate a hydrogen atom from an aromatic 
hydroxyl group to a free radical, and scavenge reactive oxygen species by forming a 
more stabilized phenolic radical (Rice-Evans et al., 1996): 
      Flavonoid (OH) + R•  → Flavonoid(O•) + RH 
Where R• is an organic free radical and O•
Both the position of hydroxyl groups on the aromatic ring and their structural 
arrangement have an effect on their antioxidant and free radical scavenging activities 
(
 denotes an oxygen-centered radical (in 
the case of flavonoids, delocalized around the phenol ring). 
Peluso, 2006; Rice-Evans et al., 1996). An o-dihydroxy structure in the B ring offers 
higher stability to the radical form and participates in electron delocalization (Rice-
Evans et al., 1996). The C2-C3 double bond, 3-OH group, and 4-oxo function in ring C 
of flavonoids exert the greatest radical scavenging potential (Rice-Evans et al., 1996).  
Additionally, the number of hydroxyl groups is positively related to antioxidant 
activity; whereas substitution of hydroxyl groups by glycosylation decreases 
antioxidant activity (Havsteen, 2002; Rice-Evans et al., 1996). Quercetin, luteolin, 
myricetin, and kaempferol exhibited greater antioxidant capacity than glyco-conjugated 
flavonoids such as quercetin-3-glucoside, quercitrin, and rutin (Ioku et al., 1995; 
Noroozi et al., 1998).  
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Flavonoids have been shown to act as scavengers of various oxidizing species 
including hydroxyl, lipid alkoxyl, peroxyl and superoxide radicals, and hypochlorous 
acid (Heim et al., 2002; Rice-Evans et al., 1996).  Flavonoids also protect molecules 
against damage caused by peroxynitrite in vitro (Heijnen et al., 2001). The capacity of 
scavenging superoxide and peroxynitrite could capably protect endothelial dysfunction 
under acute oxidative stress (Akhlaghi & Bandy, 2009). By scavenging such reactive 
species, flavonoids suppress the oxidative reactions in the system and prevent further 
formation of reactive radicals.  
Many flavonoids chelate transition metal ions such as iron and copper, decreasing 
their ability to promote reactive species formation, and thereby diminish the generated 
free radicals in the medium (El Hajji et al., 2006; Soczynska-Kordala et al., 2001). 
Quercetin and rutin were highly effective at complexing transition metal ions and 
inhibiting lipid membrane peroxidation.  
Besides ROS scavenging, flavonoids inhibit the activity of enzymes participating in 
free-radical generation. Robinetin, rhamnetin, eupatorin and baicalein showed strong 
inhibition of NADH-oxidase activity (Hodnick et al., 1994). Studies indicated that 
dietary administration of anthocyanins, proanthocyanidins, or catechin oligomers 
prevented the increased expression of cardiac NADPH oxidase in rats fed with high-
fructose diet (Al-Awwadi et al., 2005). Flavonoids also can inhibit xanthine oxidase 
and prevent formation of superoxide; flavones showed higher inhibitory activity than 
flavonols (Cos et al., 1998). 
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2.4.4.2 Interaction with cell membranes  
Importantly, flavonoids could also exert the antioxidant properties through 
interacting with and penetrating cell membranes, where their action maintains 
membrane fluidity and integrity (El Hajji et al., 2006; Heim et al., 2002; Oteiza et al., 
2005). Flavonoids can accumulate and position themselves at the lipid-water interface 
of membranes through hydrophilic and lipophilic interactions (Rice-Evans et al., 1996).  
When flavonoids interact with bilayers, those containing more hydrophobic moieties 
can position in the interior of the membrane, whereas those with more hydrophilic 
moieties can undergo hydrogen bond with the polar head groups of phospholipids and 
accumulate at the membrane interface (Oteiza et al., 2005).  The result of these 
interactions can effectively diminish the access of ROS and disrupt the reaction of lipid 
radicals with other fatty acids, thus protecting the structure and function of membranes 
against lipid and protein oxidation (Oteiza et al., 2005; Rice-Evans et al., 1996).  
Indeed, the hydrophilicity/hydrophobicity, the degree of flavanol oligomerization 
and the number of hydroxyl groups are related to the protective effects of flavonoids on 
membranes and lipid peroxidation (Heim et al., 2002). 
2.4.4.3 Reinforcement of cellular antioxidants  
The antioxidant abilities of flavonoids also apply in protection or enhancement of 
endogenous antioxidants (Elliott et al., 1992; Filipe et al., 2002; van Acker et al., 
2000). Certain flavonoids (including quercetin, myricetin, and fisetin) were shown to 
decrease oxidative stress by inducing glutathione S-transferase (GST), an enzyme 
which is among those controlled by the antioxidant response element and which 
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protects cells against oxidative stress caused by hydrogen peroxide (Fiander & 
Schneider, 2000).  
The flavonoids in biological systems also contribute to recycling and/or stabilizing 
other antioxidants. Flavonoids have the capacity to reduce the α-tocopheroxyl radical, 
regenerate α-tocopherol (Filipe et al., 2002; Rice-Evans et al., 1996).  This action 
sufficiently maintains α-tocopherol levels for longer time periods, enhances the 
antioxidant capacity of the cell and biomembranes, and delays the initiation of lipid 
peroxidation since vitamin E scavenges primarily peroxyl radicals and other reactive 
species such as alkoxyl radicals.  
Furthermore, the combination of flavonoids and ascorbate may cooperatively protect 
the membrane from lipid peroxidation in the mitochondria (Bandy & Bechara, 2001; 
Ratty & Das, 1988). Bandy and Bechara (2001) observed an ability of certain 
flavonoids to mediate electron transfer from ascorbate to a membrane interface. 
Conversely flavonoids can preserve ascorbic acid activity in a system by regenerating 
ascorbate from ascorbate radical (Cossins et al., 1998; Heim et al., 2002).  
2.4.4.4 Potential medicinal benefits in oxidative stress  
Both in vivo and in vitro investigations have confirmed the ability of flavonoids to 
help protect biosystems against free radicals and oxidative stress (Middleton et al., 
2000).  For example, after 2 hours of chocolate consumption, as a source of epicatechin 
and procyanidin; a significant increase in human plasma epicatechin concentrations 
was observed; with a significant increase (31%) in human plasma total antioxidant 
capacity (p < 0.04) and a decrease of 40% in plasma thiobarbituric acid reactive 
substances (p < 0.01) (Rein et al., 2000).  
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The effect of flavonoids on coronary artery diseases (CAD) arise from protection 
against low density lipoproteins (LDL). The flavonoids protect LDL against oxidation 
by reducing the generation of free radicals, inhibiting the generation of lipid 
hydroperoxides, sparing α-tocopherol, and chelating metal ions (de Whalley et al., 
1990). Flavonoids protect LDL from oxidation thus reducing atherogenicity; which 
potentially reduces oxidative stress related diseases including vascular disorders and 
coronary artery disease (Middleton et al., 2000; Nijveldt et al., 2001). In addition, 
dietary flavonoids can inhibit platelet activation and aggregation (Williams & 
Clarkson, 1998). In vivo evidence indicates that the consumption of flavonoids 
significantly decreases parameters of human plasma oxidant status in a dose-dependent 
manner (Rein et al., 2000).  
Flavonoids are also powerful chain-breaking antioxidants that protect cell 
membranes from oxidative damage (Oteiza et al., 2005). It was observed that 
flavonoids can replace α-tocopherol as a chain-breaking antioxidant in liver 
microsomal membranes (van Acker et al., 2000). 
In addition to antioxidant properties, flavonoids have received considerable attention 
because of their antimutagenic, anticarcinogenic, antiallergic, and anti-inflammatory 
properties (Middleton & Kandaswami, 1992; Nijveldt et al., 2001). Overwhelming 
evidence suggests that flavonoids could reduce the incidence of certain cancers, 
cardiovascular and neurodegenerative diseases, DNA damage and even may have 
antiageing properties. Excellent reviews on their potential medicinal benefits have been 
published (Darvesh et al., 2010; Havsteen, 2002; Middleton et al., 2000; Obrenovich et 
al., 2010) 
 25 
 
 2
5 
   
   
 
In short, the protective antioxidant properties of flavonoids in biological systems 
relate to their capacity to transfer electrons to free radicals, chelate metal catalysts, 
activate antioxidant enzymes, and enhance antioxidant capacity in the system by 
recycling and/or stabilizing antioxidant compounds. Protection by flavonoids against 
oxidative tissue damage has been determined by effects on lipid peroxidation, DNA 
fragmentation and protein oxidation. The capacity of flavonoids in these aspects 
provides strong evidence that flavonoids can apply in numerous disease conditions and 
have beneficial effects on human health.  
2.5 Flavonoid effects on mitochondria 
 As we are interested in the antioxidant ability of flavonoids and their potential 
medical benefits, the question arises whether flavonoids would be effective in 
protecting mitochondria against oxidative damage and thus be a possible therapeutic 
application in mitochondrial diseases.  
 Numerous studies indicate the beneficial effects of flavonoids in biological systems, 
including subcellular systems such as mitochondria and microsomes (Cavallini et al., 
1978; Haraguchi et al., 1996; Trumbeckaite et al., 2006). Fewer studies have 
documented their specific applications in mitochondrial functions. Several studies have 
reported in vitro protective effects of flavonoids against both enzymatic and 
nonenzymatic mitochondrial lipid peroxidation (Elingold et al., 2008; Middleton et al., 
2000).  
Experiments on isolated rat liver mitochondria indicated that flavonoids efficiently 
inhibited ADP/ Fe(II)-induced lipid peroxidation and were potent inhibitors of  MPT  
in Ca 2+ Santos et al., induced swelling, as well as of protein sulfhydryl oxidation (
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1998).  In addition, the flavonoid isolated from the roots of Dalea elegans 
demonstrated significant antioxidant activity and inhibited NADPH-dependent 
enzymatic lipid peroxidation in rat liver mitochondria (Elingold et al., 2008). Several 
flavonoids also inhibited nonenzymatic lipid peroxidation induced by ascorbic acid and 
ferrous sulfate in mitochondria (Ratty & Das, 1988).   
Also, flavonoids can inhibit key enzymes of mitochondrial respiration. Certain 
flavonoids show strong inhibition of  NADH-oxidase activity, depending on their 
hydroxylation/ methoxylation structural features (Hodnick et al., 1994; Santos et al., 
1998); Since NADH-oxidase is one of the main sites of ROS generation, this suggests 
that flavonoids could inhibit ROS generation in mitochondria, although it would also 
impair ATP production.  
In membrane studies relevant to mitochondria, certain flavonoids mediated a 
protective effect of ascorbate on peroxide-bleaching of membrane-bound cytochrome 
c; also, querctein combined with ascorbate could protect the membrane from 
cytochrome c-catalyzed lipid peroxidation (Bandy & Bechara, 2001). In other studies 
with this system from our laboratory (unpublished results), it was found that the 
anthocyanin cyanidin was especially effective in the cooperation with ascorbate.  
Regarding mitochondrial therapeutics, flavonoid–TPP conjugates were developed 
and purposed to act as mitochondrial targeting antioxidants (Mattarei et al., 2008). 
Mitochondriotropic quercetin derivatives were synthesized by linking the 3-OH of 
quercetin to the TPP moiety cationic group (Mattarei et al., 2008). The experiment 
indicated those compounds can accumulate in mitochondria by a transmembrane 
potential-driven process. Rather than acting as antioxidants, they inhibited 
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mitochondrial ATPase activity, produced pro-oxidant activity and MPT, and induced 
apoptosis for fast-growing cells(Mattarei et al., 2008). As such they might be useful as 
anticancer agents, but further studies are needed of their bioactivities in vivo. 
Since flavonoids are very effective antioxidants, they may have protective effects on 
mitochondrial mutation and dysfunction.  For example, epigallocatechin-3-gallate 
(EGCG) and luteolin significantly restored the mitochondrial membrane potential and 
ATP levels, and lowered ROS production in amyloid-β induced mitochondrial 
dysfunction in vitro and in vivo (Dragicevic et al., 2011).  
The biomedical properties of flavonoids have been intensely investigated in cellular 
functions; however, the uptake and effects of flavonoids in mitochondria is still 
unclear. The detailed study of their activities and utilization in mitochondria is thus a 
promising research topic, and more evidence of these compounds in mitochondrial 
targeting and potential benefits are necessary. 
2.6 Anthocyanins  
Anthocyanins and their aglycone derivatives (anthocyanidins) are an important 
group of flavonoids.  Anthocyanins are pigments that are responsible for red, blue and 
violet colours in many plants. More recently, anthocyanins have attracted considerable 
interest and extensive mechanistic studies for their potential protective effects and 
health benefits.  
2.6.1 Structural properties 
The most abundant anthocyanins in plants are the glycosides of the six 
anthocyanidins: cyanidin, pelargonidin, peonidin, delphinidin, petunidin and malvidin 
(Kong et al., 2003). The most common glycosyl groups of anthocyanidins are glucose, 
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galactose and arabinose; glycosylation provides stability to the anthocyanins and often 
occurs at C-3, and C-5 (Welch et al., 2008). The hydroxylation and sugar substitution 
influence the anthocyanin color and properties. 
 
                               
                                        Anthocyanidin                         R1                              R2 
                                        cyanidin                                  OH                             H 
                                        delephinidin                            OH                             OH 
                                        malvidin                                  OCH3                        OCH3 
                                        pelargonidin                            H                                H 
                                        peonidin                                  OCH3                           H 
                                        petunidin                                 OH                             OCH3 
Figure 2.4 Structure of six major anthocyanidins.  
 
The C ring of anthocyanins is fully unsaturated, so they present the most oxidized 
flavonoids. The anthocyanins are rather unique flavonoids; at acidic pH they have a 
positive charge associated with the C-ring in the form of a flavylium ion, and unlike 
most other flavonoids they are not negatively charged at physiological pH (Kong et al., 
2003).  
In aqueous medium anthocyanins undergo structural pH-dependent ring-chain 
tautomerism that determine their colour and stability (Mazza & Brouillard, 1987; 
Welch et al., 2008). A number of reversible reactions may occur while pH increases, 
leading to the resultant carbinol pseudo base at pH 5 and the formation of quinoidal 
base at pH 6-8 (Ghosh & Konishi, 2007; Passamonti et al., 2009) (Fig 2.5). 
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Figure 2.5 Structure of anthocyanidins in different pH.  Shown are isomers of 
pelargonidin (aglycone R = H, glycone R = sugar). Adapted from Mazza & Buillard 
(1987) and Prior & Wu (2006).  
 
The flavylium cation forms are predominantly present in acidic environments. At 
the more acidic pH of biological system, flavonols with a pKa of ~7 (Lemańska et al., 
2001) would be a mixture of neutral molecule and anion, while anthocyanins with a 
pKa of 5.5-6 for the cation (Borkowski et al., 2005; Prior & Wu, 2006) would be a 
mixture of the neutral quinoid form with the flavylium cation.  In addition to 
outstanding antioxidant abilities, the neutral and positive charge properties of 
anthocyanins compared to other flavonoids raise the reason that we are much interested 
in possible beneficial health properties of these compounds. 
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2.6.2 Antioxidant properties and protective activities against oxidative stress 
Importantly, increasing interest in the potential health benefits of anthocyanins are 
related to efficient antioxidant activity, which is stressed from two perspectives: their 
free radical scavenging properties and ability to  prevent radical formation by metal 
chelation (Kong et al., 2003). The antioxidant activity of anthocyanins and their other 
functions has been well studied, as well as the correlation between their antioxidant 
capacity and chemical structure (Welch et al., 2008). The different patterns of 
hydroxylation and glycosylation influence their antioxidant properties (Rice-Evans et 
al., 1996). Also the hydroxyl moieties of the C ring allows good metal chelation ability 
(Welch et al., 2008).   
Anthocyanins showed much stronger antioxidant ability than most other flavonoids 
in the trolox equivalent antioxidant activity (TEAC) test (Rice-Evans et al., 1996).  In 
addition, studies show that anthocyanins can have higher antioxidative activity than 
vitamin E, ascorbic acid, and β-carotene in certain systems (Kowalczyk et al., 2003; 
Rice-Evans et al., 1996; Wang et al., 1999).  
Anthocyanins present high antioxidant capacity in several lipid oxidation systems, 
which is related to their ability to inhibit lipid peroxidation by free radical scavenging 
activity and metal chelating properties (Noda et al., 2002; Tsuda et al., 1996). Three 
cyanidin-glycoside derivatives and the aglycone cyanidin isolated from tart cherries 
were evaluated in a liposome system; anthocyanins inhibited lipid peroxidation and 
presented higher antioxidant ability than vitamin E (Wang et al., 1999). Moreover, the 
result suggested that the aglycone form (cyanidin) has higher efficacy than its 
glycosides.  Studies also reported anthocyanins acted as antioxidants on human low-
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density lipoprotein (LDL) against copper ion induced oxidation in vitro (Galvano et al., 
2004).   
Just like other flavonoids, anthocyanins can scavenge various oxidizing species 
(Noda et al., 2002). Also, they can act as scavengers of peroxynitrite; cyanidin-3-O-
glucoside reduced the peroxynitrite-induced suppression of mitochondrial respiration 
and DNA damage in human umbilical vein endothelial cells in vitro, which indicated 
that anthocyanins may have protective effects against endothelial dysfunction and 
vascular failure (Serraino et al., 2003).   
In addition, the protective antioxidant ability against oxidative stress has been 
estimated in several in vivo studies. Cyanidin-glucoside oral administration lowered 
serum TBARS formation, and protected the serum against lipid peroxidation (Tsuda et 
al., 1998). The in vivo antioxidant activity of anthocyanins also was confirmed in a 
model of hepatic ischemia/reperfusion (I/R) injury (Tsuda et al., 1999a). The dietary 
administration of cyanidin-glucoside suppressed I/R-induced indices of oxidative 
damage.  Also consumption of an anthocyanins-rich diet improved plasma antioxidant 
capacity, and decreased both lipid peroxidation and DNA damage caused by vitamin E-
deficiency in rats (Ramirez-Tortosa et al., 2001). All evidence listed above indicates 
that anthocyanins possess strong antioxidant properties against oxidative damage, and 
function as potent antioxidants under oxidative stress. 
2.6.3 Biological activities of anthocyanins 
The anthocyanins have an array of health-promoting benefits. Various studies have 
shown that anthocyanins have many beneficial health effects such as reducing age-
associated oxidative stress, possessing anti-inflammatory properties, preventing cancer, 
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and protecting against vascular disease (Dai et al., 2009; Hirai et al., 2010; Kong et al., 
2003; Neto, 2007; Thomasset et al., 2009b). Anthocyanins have many biological 
properties such as antioxidant, anti-inflammatory, antimicrobial, antiatherosclerotic and 
anticancer activities, and have been utilized for therapeutic purposes (Mazza et al., 
2002; Mertens-Talcott et al., 2008; Min et al., 2010). 
Animal investigations indicate a role for dietary anthocyanins in the prevention of 
age-related diseases, such as neurodegenerative disorders and cognitive decline, which 
suggests that anthocyanins may have effects on the ageing process of the brain 
(Goyarzu et al., 2004; Joseph et al., 2003).  Due to evidence of anthocyanins’ potential 
value in the treatment and prevention of oxidative stress-related diseases, these dietary 
bioactive constituents have been recommended as health-promoting products or 
nutritional supplements instead of drug products (Dai et al., 2009). 
In diabetes, anthocyanins have shown promise in limiting ocular and cardiovascular 
complications. The anthocyanin extracts of Vaccinium fruits have been widely studied 
and used in the treatment of ocular and vascular alterations and diabetes mellitus 
(Ghosh & Konishi, 2007; Mills & Bone, 2000). Anthocyanin supplements have been 
shown to improve visual acuity, protect against retinal disorders including glaucoma 
and cataracts, and also be effective in diabetic retinopathy prevention (Ghosh & 
Konishi, 2007). In rats fed a high-fructose diet, the administration of anthocyanins 
prevented hypertension, cardiac hypertrophy and production of ROS, and expression of 
NADPH oxidase (Al-Awwadi et al., 2005). 
The “French paradox”, which is the observation of a relatively low incidence of 
coronary heart disease in French people,has been primarily related to the regular 
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consumption of polyphenol-rich red wine (Lippi et al., 2010). Anthocyanins contribute 
predominately to the total antioxidant activities and vascular effect of red wine (Rivero-
Perez et al., 2008), and so may be important contributors to the French paradox. In 
vitro laboratory studies indicate that anthocyanins may help maintain a healthy vascular 
system by several mechanisms. Anthocyanin extracts are effective in decreasing 
capillary permeability and fragility, and possess stronger anti-inflammatory and anti-
oedema activities than flavonols, which suggests they are potential medical compounds 
against tissue inflammation or capillary fragility (Kong et al., 2003).  
Effects of anthocyanins on vascular diseases include: (a) stabilizing connective 
tissue, (b) promoting collagen formation and (c) helping to prevent oxidative damage to 
blood vessels (Andres-Lacueva et al., 2005). Anthocyanins could stabilize the 
phospholipids of endothelial cells and improve the synthesis of collagen and 
mucopolysaccharides, and thus have protective effects on the endothelium of the 
vascular wall (Mian et al., 1977).  Also, anthocyanins induce  vasorelaxation, related to 
increased synthesis and release of endothelial nitric oxide (Mendes et al., 2003; Rivero-
Perez et al., 2008). 
A prospective epidemiological study indicated an inverse relationship between 
anthocyanin consumption and the risk of cardiovascular disease (Mink et al., 2007). 
Postmenopausal women (n = 34,489) involved in the Iowa Women's Health Study after 
16 y of follow-up, had significant inverse associations between anthocyanin 
consumption, strongest among the flavonoids, and mortality of CVD and CHD after 
multivariate adjustment. Red wine intake was associated with a significant reduction in 
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CHD and CVD mortality, and a significant reduction of mortality was also related with 
the consumption of strawberries and blueberries.   
Anthocyanins also show potential anticancer activities. Anticancer properties of 
anthocyanins were present in inhibiting the growth of a range of tumor cells and 
inducing apoptosis (Chen et al., 2005; Dai et al., 2009; Hyun & Chung, 2004).  
Anthocyanins also have been investigated in clinical trials. In one trial (Thomasset et 
al., 2009a) 25 colorectal cancer patients were taking mirtocyan, an anthocyanin-rich 
standardized bilberry extract, daily for 7 days before having resection of primary tumor 
or liver metastases. Anthocyanin concentrations were detected in plasma, colorectal 
tissue and urine, and tumor tissues had decreased proliferation and increased apoptosis.  
Recently, studies also showed that cyanidin and its derivatives exhibit anti-diabetic 
activity, which gives benefit for the prevention of obesity and diabetes (Nasri et al., 
2011; Sasaki et al., 2007; Tsuda et al., 2003). 
2.6.4 Bioavailability and distribution in tissues 
Many studies have investigated anthocyanin absorption and metabolism both in 
human and experimental animals, and fruit extracts were mainly used as anthocyanin 
sources (Bub et al., 2001; Cao & Prior, 1999; Matsumoto et al., 2001; Mazza et al., 
2002; Prior & Wu, 2006). Anthocyanins are rapidly and directly absorbed, and 
anthocyanin consumption resulted in a significant increase in plasma and serum 
antioxidant capacity (Hassimotto et al., 2008; Mazza et al., 2002).  
The bioavailability and tissue distribution of anthocyanins were evaluated in a rat 
model using a bilberry extract that contained 15 different anthocyanins, and the results 
showed that the bioavailability of anthocyanins was in the range of 0.61-1.82% (0.93% 
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as the anthocyanin mixture) (Ichiyanagi et al., 2006). The Hassimotto group established 
that cyanidin glycosides absorption  AUC0-8h 
Hassimotto et al., 2008
(area under the curve of concentration 
versus time) was 2.76 ± 0.88 µg hour/mL and 9.74 ± 0.75 µg hour/g for plasma and 
kidney after 125 mg wild mulberry extract (79% cyanidin-3-glucoside, 19% cyanidin-
3-rutinoside) per kg body weight oral administration ( ). 
In addition, anthocyanin absorption and metabolism are suggested to depend on the 
core phenolic aglycones and conjugated carbohydrate moieties (Ichiyanagi et al., 2006; 
Matsumoto et al., 2001; McGhie et al., 2003; Wu et al., 2005). Also, studies suggest 
that anthocyanin glycosides, unlike other flavonoids, are absorbed and distributed in 
their intact, unmetabolized forms (Cao & Prior, 1999; Matsumoto et al., 2001).  
Anthocyanins have an affinity for tissues such as kidney and skin and can 
accumulate in tissues (Matsumoto et al., 2006a). Studies in rats, rabbits and pigs have 
shown anthocyanin absorption from the stomach and intestines to be present in plasma, 
liver, kidney, brain and ocular region, and unlike other flavonoids, to be excreted in 
urine in unmetabolized forms (Andres-Lacueva et al., 2005; Hassimotto et al., 2008; 
Ichiyanagi et al., 2004a; Ichiyanagi et al., 2004b; Ichiyanagi et al., 2006; Ichiyanagi et 
al., 2005; Kalt et al., 2008; Matsumoto et al., 2006a; Matsumoto et al., 2006b; 
Passamonti et al., 2005; Talavéra et al., 2005; Tsuda et al., 1999b). A summary of 
tissue distribution studies and the detailed methods and results are listed in Table 2.2. 
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Table 2.2 Previous studies reporting the presence of anthocyanins in tissues when administered via different protocols. 
Model Administration Dose 
per kg body weight 
Time period Detected in tissues and body fluid Reference 
Rat Intravenous 5mg bilberry extract (1.9 mg anthocyanins, 
0.228ng cyanidin glycones)    
Single dose.  
15 mins. Liver, kidney, bile, plasma (1.2 µM)  
urine.  
(Ichiyanagi et al., 2006) 
 
Rat Oral 400 mg bilberries extract (153.2 mg 
anthocyanins, 0.01824mg cyanidin glycones). 
Single dose. 
15 mins. Liver (cyanidin glycones 7.54 
pMol/g), kidney (cyanidin glycones 
32.55 pMol/g), bile, plasma (cyanidin 
glycones 0.14 µM), urine. 
Rat  Intraperitoneal  500 mg blackcurrant powder (108 mg 
anthocyanins). Single dose. 
30 min, 1 h, 2 h, 4 
h, 8 h and 
24 h. 
Plasma (2.30 ±0.76 µg/ml (Cmax) 
anthocyanins after 1h), ocular region 
(4.99 ± 0.48 ng/g (Cmax) anthocyanins 
after 2h).   
(Matsumoto et al., 2006b) 
 
Rat  Oral  463 mg blackcurrant powder (100 mg 
anthocyanins). Single dose. 
30 min, 1 h, 2 h, 4 
h, 8 h and 
24 h. 
Plasma (1.94±0.44 µg/ml (Cmax) 
anthocyanins after 30 min),ocular 
region (115 ± 32 µg/g (Cmax ) 
anthocyanins after 30 min). 
Rabbits  Intravenous  96.2 mg blackcurrant powder (20mg 
anthocyanins). Single dose. 
30 min, 1 h, 2 h, 4 
h, 8 h and 
24 h. 
Plasma (12.42 ± 1.25 µg/ml (Cmax) 
anthocyanins after 30 min), ocular 
region (sclera 3.02 ± 0.09 µg/g, 
choroid 3.00 ± 0.06 µg/g, ciliary body 
2.04 ±0.28 µg/g anthocyanins after 30 
min).   
Rat  Oral 152 µMol delphinidin-3-rutinoside from 
blackcurrant extract. Single dose. 
1, 5, 15, 30, 60, 
and 120 min. 
Bile, plasma (Cmax 9.255 ± 5.472 
µMol/L, Tmax of 26.3 min) (270 ± 70 
nMol after 30 min), urine. 
(Matsumoto et al., 2006a) 
Rat Intravenous 7.62 µMol delphinidin-3-rutinoside from 
blackcurrant extract. Single dose. 
1, 5, 15, 30, 60, 
and 120 min. 
Bileplasma (Cmax 0.285 ± 0.071 
µMol/L, Tmax of 26.3 min), urine. 
Rat Oral 100 mg cyanidin 3-O-beta-D-glucopyranoside 
extracted from blackcurrant extract. Single 
dose. 
15, 30, 60, 120, 
240, 360, and 480 
min. 
Plasma (maximum 0.18 µM after 
30mins), urine. 
(Ichiyanagi et al., 2005) 
 
Rat Intravenous 2 mg cyanidin 3-O-beta-D-glucopyranoside 
extracted from blackcurrant. Single dose.  
15, 30, 60, 120, 
240, 360, and 480 
min. 
Plasma, urine. 
Rat  Oral  100mg delphinidin 3-O-beta-D-
glucopyranoside extracted from blackcurrant. 
Single dose.  
15, 30, 
60, 120, or 240 
min. 
Liver, kidney, urine, plasma (0.4 µM 
in 15mins.,and 30 nM after 4h) 
(Ichiyanagi et al., 2004b) 
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Rat  Oral  100mg delphinidin 3-O-beta-D-
glucoside extracted from blackcurrant. Single 
dose. 
15, 30, 
60, 120, or 240 
min. 
Liver, kidney, urine, plasma 
(appeared at 15min). 
(Ichiyanagi et al., 2004a) 
Rat  Gavage  0.9 mMol cyanidin 3-O-beta-D-glucoside. 
Single dose. 
15, 30, 60, 120, or 
240 min. 
At 30 min, stomach (about1.5 
µMol/g), jejunum (about 0.14 
µMol/g), kidney (3.20 ± 0.26 
nMol/g), liver (about 0.6 nMol/g), 
plasma (0.31 ± 0.03 µMol/L). 
(Tsuda et al., 1999b) 
Rat Gavage 125mg wild mulberry extract (79% cyanidin-3-
glucoside, 19% cyanidin-3-rutinoside). Single 
dose.  
15, 30, 60, 120, 
180, 240, and 480 
min. 
Kidney (9.74 ± 0.75 µg hour/g), 
gastrointestinal tract (about 9mg in 
stomach), plasma (2.76 ± 0.88 µg 
hour/mL)  
(Hassimotto et al., 2008) 
Rat  Surgically induce into 
stomach 
8 mg anthocyanin extracted from grapes. Single 
dose. 
10 min. Brain (192.2 ±57.5 ng/g), plasma 
(176.4 ±50.5 ng/mL). 
(Passamonti et al., 2005) 
Rat  Ad libitum  0.4 mg blueberry extract in diet. 10 weeks. 10 weeks. Brain, plasma. (Andres-Lacueva et al., 
2005)  
Rat  Ad libitum 15 mg blackberry extract (1.48mMol/kg diet 
anthocyanins , and > 90% cyanidin 
glucosides)in diet. 15 days. 
sacrificed at 3 h 
after the 
beginning of the 
last meal. 
Brain (cyanidin glucoside 0.21 ± 
0.05nMol/g, stomach (cyanidin 
glucoside 62.9 ± 5.4 nMol/g), 
jejunum (cyanidin glucoside 485 ± 54 
nMol/g), kidney (cyanidin glucoside 
2.16 ± 0.94 nMol/g, liver (cyanidin 
glucoside 0.05 ± 0.01nMol/g), urine 
(0.62 ± 0.08 µMol/24h), plasma (0.36 
± 0.02µMol/L). 
(Talavéra et al., 2005) 
Pig Ad libitum 2% blueberry powder in diet (8.5 µMol 
anthocyanins). 30 days. 
30 days. Liver (1.3 pMol/g),eyes(1.58 
pMol/g), cortex (0.878 pMol/g FW), 
cerebellum (0.664 pMol/g FW).  
(Kalt et al., 2008) 
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In summary, studies on the absorption and metabolism of anthocyanins have been 
reported mostly during the past two decades. They have suggested that anthocyanins can 
accumulate in tissues and are absorbed intact, and absorption can be saturated. Interest in 
the in vivo bioavailability of anthocyanins arises from evidence supporting a role for 
these flavonoids in human health.  
However, such studies using fruit extracts as anthocyanin sources are not suitable for 
precise discussion of anthocyanin pharmacokinetics. Also, there is no study that 
compares absorption and accumulation between other flavonoids and anthocyanins.  
More importantly, the question of anthocyanidin distribution and levels in subcellular 
organelles such as mitochondria has not been documented. With respect to oxidative 
stress damage, the information of mitochondria and specific tissues distribution of pure 
anthocyanins and their effects is critically needed.  
2.7 Summary and Critical considerations 
Flavonoids are considered to be  promising dietary compounds with a potential 
beneficial roles in human health. It is suggested that flavonoids have efficiency against 
oxidative damage and preventing oxidative stress related diseases due to their powerful 
antioxidant and radical-scavenging activities. Flavonoids have been shown to be absorbed 
and accumulate in tissues and plasma where they could exert antioxidant activities. 
Experimental data have demonstrated that flavonoids can protect cell components against 
oxidative damage both in vitro and in vivo. Still the details on concentrations and 
metabolic mechanism in tissues and cells after flavonoids administration are uncertain. 
Also, the question remains how flavonoids enter the cells and whether they could 
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accumulate in subcellular organelles such as mitochondria where the antioxidant and 
other activities could be exerted.   
Anthocyanins could provide potential pharmacological or functional food therapies 
against oxidative stress because of their strong antioxidant ability and unique 
characteristics. The anthocyanins are unique among the flavonoids in not being 
negatively charged at physiological pH, and show especially efficient antioxidant 
activities and free radical scavenging properties. The in vitro antioxidant activities of 
anthocyanins and protective mechanism among their structural properties are highly 
studied recently. The antioxidant efficacy in vivo of anthocyanins has been less 
thoroughly documented, and further confirmation is still needed. Also, with regards to 
anthocyanins there are still fewer studies compared to studies of other flavonoids. 
Lipophilic cations can be used to target an attached antioxidant to mitochondria 
(Armstrong, 2008), and in principle anthocyanins may have a positive charge at the acidic 
interface of the mitochondrial membrane. This raises the question of whether 
anthocyanins may exert protective effects against the oxidative damage implicated in 
mitochondria.  
Many experiments indicate anthocyanins are rapidly absorbed, and can reach the 
tissues, and anthocyanins consumption resulted in significant increases in plasma and 
serum antioxidant capacity.  For further discussion on in vivo function of anthocyanins in 
system, it is critical to know the physiological uptake and distribution of each 
anthocyanin in tissues and perhaps especially in mitochondria. However, there are no 
data on the potential ability of anthocyanins to reach and affect mitochondria. For a better 
understanding of their potential health effects, this information is both essential and 
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necessary. The main goal of this research was to provide detailed evidence about 
anthocyanin uptake by mitochondria and distribution in tissues and mitochondria that 
may relate to their health benefits in preventing oxidative stress and age-related disease.   
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3. HYPOTHESIS AND OBJECTIVES 
3.1 Hypothesis 
The anthocyanins, to a greater extent than other flavonoids will be driven by an 
electrical potential mechanism into mitochondria, where they will have protective effects. 
Thus, during treatment with pure anthocyanins in vitro or in vivo, mitochondria isolated 
from rat liver would show an increased content of anthocyanins; and decreased 
susceptibility of mitochondria to oxidative damage. 
3.2 Objectives  
 The overall objective of my thesiswas to compare the mitochondrial uptake and 
antioxidant activities of selected flavonoids after delivery in vitro and in vivo. Cyanidin, 
quercetin and their 3-glucosides were studied in rats and isolated rat liver mitochondria.  
Specific objectives were: 
1. In vitro, to determine the relative mitochondrial loading of the selected flavonoids, 
the involvement of mitochondrial membrane potential in uptake, and the impact on 
mitochondrial respiration and susceptibility to oxidative stress.  
2. In vivo, to analyze and compare the distribution and protective effects of 
intravenously delivered flavonoids on tissues and mitochondria.  
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4. MATERIALS AND METHODS 
4.1 Experimental animals and chemicals 
This work was approved by the University of Saskatchewan’s Animal Research Ethics 
Board, and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use. For all experiments, adult male Wistar rats (250-300 g body weight) were 
used and purchased from the University of Saskatchewan Animal Resource Centre. 
Animals were housed in a temperature- (22°C ± 2°C) and humidity- (50±10%) controlled 
facility on 12h light/dark cycles (0700 h – 1900 h) in accordance with the guidelines of 
the Canadian Council on Animal Care. The rats were fasted overnight prior to the 
experiment.  
There were four selected flavonoids tested in this study: cyanidin (CY), cyanidin-3-O-
glucoside (C3G), quercetin (QU) and quercetin-3-glucoside (Q3G). Chemicals, unless 
specified, were purchased from Sigma-Aldrich (St. Louis, MO). Cyanidin chloride and 
kuromanin chloride (cyanidin-3-O-glucoside chloride) were obtained from Extrasynthese 
SA (Z.I Lyon Nord. France). 
4.2 In vitro study  
4.2.1 Mitochondrial uptake measurements 
4.2.1.1 Mitochondria isolation 
Mitochondria were isolated from rat liver following humane euthanasia (isoflurane 
anesthesia and decapitation) and rapid removal of organs. Briefly, freshly excised liver 
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was cut into small pieces and homogenized using a glass-teflon homogenizer with an ice-
cold isolation medium containing 250 mM sucrose, 10 mM HEPES and 1 mM EGTA, 
pH 7.2 (~4 mL/g tissue). The homogenate was then centrifuged at 1000 g for 8 min at 
4°C. The supernatant was collected and centrifuged at 10,000 g for 10 min at 4°C. The 
pellet was resuspended in washing medium containing 250 mM sucrose, 10 mM HEPES 
and 0.1 mM EGTA (pH 7.2) and again centrifuged at 10,000 g for 10 min at 4°C. The 
final pellets of mitochondria were suspended in 2 mL of isolation medium without EGTA 
(pH 7.2). 
4.2.1.2 Mitochondria treatment/loading conditions 
Test flavonoids at 125 µM were incubated with fresh RLM (1 mg/mL of protein) in 1 
mL sucrose-HEPES buffer (250 mM sucrose, 10 mM HEPES, pH 7.2) in the presence 
and absence of a respiratory substrate (succinate 5 mM), and an uncoupler (CCCP, 2 µM) 
in room temperature for 10 min. The mitochondria were then centrifuged at 15,000 g for 
10 min at 4 °C in the presence or absence of 2 mg/mL BSA, which adsorbs flavonoids, to 
determine the amount of flavonoids which entered the mitochondria compared to that 
which adhered to the surface. CY, C3G, and QU stock solutions (25 mM) were prepared 
in ethanol (with 0.1% HCl), and Q3G was in methanol (with 0.1% HCl). The flavonoids 
stock solutions were diluted in sucrose-HEPES buffer before use. A control incubation of 
RLM in the absence of added flavonoid was also performed. The mitochondrial pellets 
were stored in the -20°C freezer for later analysis. All incubations were done in duplicate. 
4.2.1.3 Spectrophotometric analysis of flavonoid uptake 
Initially, 125 µM test flavonoid with reaction medium was scanned at room 
temperature in the wavelength range 400-650 nm (CY and C3G) and 260-500 nm (QU 
and Q3G) by a Beckman DU 640 spectrophotometer with temperature control. After 
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mitochondrial loading, the supernatant was rescanned to measure the content of 
flavonoids. The uptake of flavonoid by fresh RLM was indicated by the difference of 
absorbance between the initial reading and the supernatant reading (i.e. loss of 
absorbance).  The absorbance wavelength chosen in calculation for CY was 576 nm, for 
QU was 376 nm, and for C3G and Q3G were 562 nm and 365 nm respectively.           
4.2.1.4 HPLC analysis of flavonoid uptake 
Quantification of flavonoids in mitochondrial pellets was performed on a Waters 
Alliance 2695 HPLC system fitted with a Waters 2996 photodiode array detector and a 
Waters Fraction Collector III. The HPLC system was controlled by Empower Software. 
The analysis was carried out on a 250 mm×4.6 mm VARIAN Inertsil C8 
Two different mobile phase systems were used in the flavonoids analysis.  Both 
mobile phase systems contained a combination of polar solvent A and a less polar solvent 
B.  HPLC analysis methods in this study are shown in Table 4.1. All solvents were HPLC 
grade (Aldrich-Sigma), and water was purified via a Milex Q-plus system (Millipore). 
The elution was performed using a solvent gradient system, the mobile phase flow rate 
was 1.2 mL/minute and the sample injection volume was 30 µL.  
reverse-
phase column (5 μm) at 25 ± 1°C. Flavonoid content detection was achieved 
spectrophotometrically with monitoring at wavelengths of 528 (CY), 520 (C3G), 374 
(QU), and 365 (Q3G) nm.  
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Table 4.1 Summary of flavonoid HPLC analysis profiles. 
HPLC profiles for selected flavonoids Mobile phases solvents Elution profiles  
Cyanidin A: water+1% formic acid 
B: methanol +0.1% formic acid 
0 - 0.5 min, 5% B (v/v);  
0.5 - 20 min, linear gradient from 5 to 60% B (v/v);  
20 - 22 min, linear gradient from 60 to 95% B (v/v);  
22 - 25 min, isocratic elution with 95% B (v/v);  
25 - 28 min, linear gradient from 95 to 5% B (v/v);  
28-30 min, isocratic elution with 5% B (v/v). 
Cyanidin-3-glucoside A: water+1% formic acid 
B: methanol +0.1% formic acid 
0 - 0.5 min, 5% B (v/v);  
0.5 - 15 min, linear gradient from 5 to 60% B (v/v);  
15 - 17 min, linear gradient from 60 to 95% B (v/v);  
17 - 20 min, isocratic elution with 95% B (v/v);  
20 - 23 min, linear gradient from 95 to 5% B (v/v); 
23 - 25 min, isocratic elution with 5% B (v/v). 
Quercetin A: water+0.1% formic acid 
B: methanol +0.1% formic acid 
0 - 0.5 min, 10% B (v/v);  
0.5 - 10 min, linear gradient from 5 to 60% B (v/v);  
10 - 20 min, isocratic elution with 60% B (v/v);  
20 - 23 min, linear gradient from 60 to 10% B (v/v); 
23 - 25 min, isocratic elution with 10% B (v/v). 
Quercetin-3-glucoside A: water+0.1% formic acid 
B: methanol +0.1% formic acid 
0 - 0.5 min, 10% B (v/v); 
0.5 - 10 min, linear gradient from 5 to 60% B (v/v); 
10 - 20 min, isocratic elution with 60% B (v/v);  
20 - 23 min, linear gradient from 60 to 10% B (v/v); 
23 - 25 min, isocratic elution with 10% B (v/v). 
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The mitochondria pellets after incubation with the flavonoids and centrifugation 
(with and without added BSA) were resuspended in methanol with 0.1% HCl (except 
with QU in ethanol with 0.1% HCl). The samples were vortexed 15 seconds and left to 
stand for 10 min at room temperature, and then centrifugated at 15000g for 10 min at 
4 °C. The supernatants were filtered (0.2 µm pore size) before injecting onto the HPLC 
system. All samples were analyzed in duplicate, and standards were in triplicate. The 
flavonoid standards were employed for retention time and quantification. Calibration 
equivalents of spectral peak area versus analyte concentration were plotted from 
various standard concentrations. Calibration curves of these standards had correlation 
coefficients of 0.99 or greater. 
For C3G there was a slight shoulder present in the HPLC chromatograms 
(Appendix B). In order to determine the possible reason, the 15µM and 1.5µM C3G 
standard solutions were also analyzed by mass spectrometry (presented in Appendix C) 
which showed that the shoulder was likely due to different isomers.  
4.2.2 Mitochondrial respiration rate measurements 
Respiration rates were measured with a Clark-type electrode (Oxytherm System; 
Hansatech Instruments Ltd, Norfolk, England) in a water-jacketed glass chamber with 
magnetic stirring. The respiration chamber was kept at 30°C. Oxygen uptake 
measurements were carried out in 1 mL respiratory buffer (125 mM sucrose, 65 mM 
KCl, 10 mM HEPES, 2 mM KH2PO/K2HPO, 1 mM MgCl2, pH 7.2), with succinate 
(5mM) and respiratory cocktail (5 mM each of malate, glutamate, pyruvate and α-
ketoglutarate) as substrates. Initially, fresh RLM (3 mg protein) were added into the 
reaction medium, and a conventional respiratory experiment with transitions from state 
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4 to 3 was performed (Estabrook, 1967).  
The trace of oxygen consumption was recorded in the absence (respiration state 4) 
and in the presence (respiration state 3) of 250 nmol ADP to determine the respiratory 
control ratio (RCR) and ADP/O ratios. The effect of 125 µM flavonoids on state 4 
respiration was measured to test for inhibitory or uncoupling effects.  
4.2.3 Mitochondrial ROS generation  
The effect of flavonoids on antimycin-stimulated mitochondrial ROS generation 
was measured with the cell permeable fluorogenic probe 2’,7’-dichlorofluorescin 
diacetate (DCFDA). ROS generation was measured both in RLM membranes incubated 
in the presence of added flavonoids (125 µM) and in the RLM pre-loaded with 
flavonoids (described in section 4.2.1.2). The RLM membranes were prepared by re-
harvesting (15,000 g for 10 min at 4o
To measure ROS generation RLM membranes or pre-loaded RLM (1 mg/mL of 
protein) were incubated in respiration buffer with 2.5 mM succinate and 2.5 mM 
respiratory substrate cocktail, 3 µM antimycin and 5 µM DCFDA, at 30°C with 
shaking for 30 min. After incubation, the samples were centrifuged at 15,000 g for 10 
min at 4 °C. The fluorescence of aliquot supernatants was measured using a Biotek 
plate reader at 485/20 excitation and 530/25 emission with a sensitivity of 45. The 
control tests (mitochondria only, and with CCCP) were also performed at the same time.  
C) frozen-thawed RLM.  
4.2.4 Lipid peroxidation assay with flavonoids treatments 
The effect of flavonoids, added to the incubation medium or present in the 
mitochondria after loading, on lipid peroxidation induced by t-butyl hydroperoxide was 
determined by the formation of thiobarbituric acid reactive substances (TBARS). The 
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TBARS assay was adapted from the methods of (Ohkawa et al., 1979) and (Fraga et al., 
1988) with some modifications. Basically, the method analyzes reactive aldehydes such 
as malondialdehyde (MDA) generated under the test conditions. At low pH and high 
temperature, TBA reacts with such aldehydes and yields a fluorescent product. 
Commonly, the formation of TBARS can be detected by absorbance because of its pink 
chromophore with an absorption maximum around 532 nm. In this study because of the 
absorption of anthocyanins at 532 nm, TBARS quantification employed the 
fluorescence method (Fraga et al., 1988) measuring at 485/20 excitation and 540/25 
emission with a sensitivity of 80. The TBARS assays were performed simultaneously 
with different MDA concentration standards (prepared from tetraethoxypropane by 
acid hydrolysis) to establish the MDA equivalents standard curve. 
For the experiments with flavonoids added to the incubation medium, RLM 
membranes were resuspended in 1.15% KCl solution, and the protein content was 
measured. Resuspending in 1.15% KCl avoids the use of sucrose, which at high 
concentrations gives a false positive in the TBARS assay. The RLM membranes (1 
mg/mL of protein) were then added in a suitable volume of 50 mM potassium 
phosphate buffer (pH 7.2), with selected flavonoids (125 µM) and incubated at 37°C 
for 60 min with 1 mM t-buOOH.  
For the experiments with flavonoid pre-loaded mitochondria, RLM were preloaded 
with flavonoid using the loading method 4.2.1.2 in the absence of substrates. The RLM 
pellets after pre-loading and centrifugation were then resuspended (at 1 mg/ml of 
protein) in the 50 mM potassium phosphate buffer (pH 7.2), and incubated at 37°C for 
60 min with 1 mM t-buOOH. 
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To measure TBARS, aliquots from the incubations were mixed with 4 times the 
volume of incubation solution containing 8.1% SDS, 20% acetic acid (pH 3.5), 0.8% 
TBA and 0.02% BHT and heated at 95°C for 60 min. The TBARS products were 
extracted into an equal volume of butanol/pyridine (v: v.15:1). The fluorescence of the 
butanol layer was measured as described above. 
4.2.5 Protein measurement 
For all of the mitochondrial and tissue samples in study I and II, protein contents 
were measured by the biuret assay. Sample aliquots were incubated with 9 times the 
volume of biuret reagent (32 mM potassium sodium tartrate, 12 mM copper sulfate, 30 
mM potassium iodide, 0.2 M NaOH) for 20 min at room temperature. Sample 
absorbance was then measured at 550 nm. Calibration curves with correlation 
coefficients of 0.99 or greater were established using BSA as the standard.  
4.3 In vivo study 
4.3.1 Experimental animals and treatments  
Twenty five male Wistar rats (250-300 g body weight) were assigned randomly 
into 5 groups (n = 5/group) in this part of study. 
Group 1: - control group – intravenous administration of vehicle.  
Group 2: - intravenous administration of CY  
Group 3: - intravenous administration of C3G. 
Group 4: - intravenous administration of QU.  
  Group 5: - intravenous administration of Q3G. 
Cyanidin, quercetin or their 3-glucosides were administered into the rat tail vein to 
give a dose of 7.6 µmol/Kg body weight according to Matsumoto’s studies (Matsumoto 
et al., 2006a; Matsumoto et al., 2006b). The rats were fasted overnight prior to injection. 
 50 
 5
0 
   
   
 
The stock flavonoid solutions at 7.6 mM were prepared in 50% polyethylene glycol 
(PEG) 400 as the vehicle (Neervannan, 2006), and directly injected into tail vein (under 
isoflurane anesthesia) according to body mass. One group was treated as control and 
received 50% PEG 400 instead of flavonoids. The rats were returned to their cages and 
provided with water but were not fed.  
After 30 min, which is a point after which more than 80% of an intravenous dose 
of anthocyanin (delphinidin-3-rutinoside) was cleared from plasma (Matsumoto et al 
2006a), a blood sample was collected from the heart under anesthesia into heparin-
containing tubes, and was centrifuged at 4000 g for 8 min at 4°C to collect the plasma. 
The rat body was perfused transcardially with cold phosphate buffered saline (PBS) for 
2-3 min at a rate of 52 mL/min to remove the blood in organs, and the liver, heart, 
kidney and brain were removed. Half of the liver and the other organs were well 
washed, wrapped in aluminum foil, frozen in liquid nitrogen, and stored in a -80°C 
freezer. RLM were immediately isolated (method as in 4.2.1.1) from half of the liver. 
The RLM, post-mitochondrial supernatant, and plasma samples, were stored at -80o
4.3.2 HPLC analysis of flavonoids distributed in tissues, mitochondria and plasma 
C 
for further analyses.  
All HPLC analyses in this research section were performed on an Agilent 
Technologies 1100 Series HPLC system (Agilent Technologies Canada Incorporated, 
Mississauga, ON). The HPLC system consisted of a binary pump (model G1310A), a 
solvent degasser (model G1379B), an autosampler (model G1367B), a column 
compartment (model G1316A), and a multi wavelength detector (MWD; model 
G1365D).  The analysis was carried out with the same column and test condition as in 
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4.2.1.4. The HPLC analysis profiles were as in Table 4.1. The mass spectra of the 
flavonoid standards were employed in sample flavonoid identification and 
quantification. Calibration curves using standards were employed. The extraction 
recovery rates of flavonoids from tissues, RLM and plasma were also performed by 
adding known quantities of flavonoids to control samples. 
4.3.2.1 Tissue sample extraction 
All tissue samples were crushed into a powder under liquid nitrogen using a 
Bessman tissue pulverizer (BioSpec, Bartlesville, OK) before the extraction process. 
The protocol of flavonoids extraction from tissues was designed according to several in 
vivo studies (Miniati, 2007; Talavéra et al., 2005). Briefly, a portion of frozen tissue 
powder (approximately 50 mg) was homogenized in an appropriate volume of 
methanol with 1% formic acid at a ratio of  9 mL to 1 g tissue. Samples were 
homogenized using a Potter-Elvehjem (glass-Teflon) homogenizer. The supernatant 
was collected after centrifuging at 4000 g for 8 min at 4°C. The pellet was re-extracted 
with methanol with 1% formic acid at 4 mL per g of tissue and centrifuged as above. 
All of the extracts obtained above were combined and evaporated to dryness using 
rotary evaporation under vacuum (≤30°C). The dried tissue extracts were then 
redissolved in methanol with 0.1% HCl (QU in ethanol with 0.1% HCl) and 
centrifuged at 12,000 g for 5 min at room temperature. The supernatants were filtered 
(0.2 µm pore size) before being applied to the HPLC system.   
4.3.2.2 Mitochondria extraction 
RLM samples (20 mg protein) were centrifuged at 15,000 g for 10 min at 4°C, the 
pellets were resuspended and homogenized in methanol with 0.1% HCl (QU in ethanol 
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with 0.1% HCl), followed by centrifugation as above. The supernatants were filtered 
(0.2 µm pore size) before being injected into the HPLC system.  
Also in this study, we attempted flavonoid analysis in post-mitochondrial 
supernatants. One 50 mL post-mitochondrial supernatant was chosen from each 
flavonoid group, and placed in freeze-drying chambers until dry (~ 24 hours). The 
samples were extracted with 2 mL methanol containing 1% formic acid; the extracts 
were then evaporated to dryness using rotary evaporation under vacuum (≤30°C).  The 
dried tissue extracts were then redissolved in methanol containing 0.1% HCl (QU in 
ethanol containing 0.1% HCl) and centrifuged at 12,000 g for 5 min at room 
temperature. The supernatants were filtered (0.2 µm) before being applied to the HPLC 
system. However, flavonoid levels in these samples were not detectable. 
4.3.2.3 Plasma extraction 
A 500 µL portion of plasma was adjusted to pH 2.5 with 150 µL of 1 M potassium 
dihydrogen phosphate solution and 15 µL 85% phosphoric acid, and then 2.5 mL 
acetonitrile was added and the samples were vortex mixed for 1 min and centrifuged at 
3500 g for 10 min at 5°C (Miniati, 2007). The supernatant liquors were evaporated to 
dryness using rotary evaporation at room temperature. The sample residues were 
extracted and HPLC-MS analysis was performed as described above.  
4.3.3 Endogenous TBARS of tissues  
Weighed samples (about 50 mg) of the frozen powdered tissues were homogenized 
with 200 µL RIPA buffer (50mM Tris, 150 mM KCl, 1%Triton X-100, 1% sodium 
deoxycholate, 0.1% EDTA, pH 7.4), and after incubation at room temperature for 30 
min to allow dissolution of the tissues, were centrifuged at 10,000 g for 10 min at 4°C. 
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The supernatants were heated with 4 times the volume of incubation solution 
containing 8.1% SDS, 20% acetic acid, 0.8% TBA and 0.02% BHT at 95°C for 60 min, 
and TBARS analysis was performed (as in 4.2.4). The protein measurement was also 
performed on the homogenates. 
4.3.4 Susceptibility of RLM to TBARS formation ex vivo 
Frozen-thawed RLM were reharvested (15,000 g for 10 min at 4o
4.4 Statistical Analysis 
C), resuspended 
in 1.15% KCl solution, and protein contains were measured. The RLM were then 
incubated at 1 mg protein/mL in 50 mM potassium phosphate buffer (pH 7.2) with 1 
mM t-buOOH at 37°C for 60 min. The TBARS tests were completed as described 
previously (4.2.4).  
Results are presented as means ± SEM. Data were analyzed by one-way analysis of 
variance with Tukey’s Honestly Significant Differences (HSD) post hoc analysis, and 
differences were considered statistically significant at p< 0.05.  
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5. RESULTS 
5.1 In vitro study 
5.1.1 Flavonoid accumulation in mitochondria in vitro study 
Comparing of the uptake of the different flavonoids in freshly prepared RLM using 
both the spectrophotometric method (Figure 5.1) and HPLC analysis of the 
mitochondrial pellet after centrifugation (Figure 5.2) showed large differences between 
the flavonoids. The two methods gave very good agreement, although the spectrometric 
method gave higher values. Representative spectrometric scans are presented in 
Appendix A, and representative HPLC chromatograms are presented in Appendix B. 
Notably, the uptake of CY in isolated mitochondria was significantly higher than the 
other three flavonoids under all experimental conditions examined (p <0.05) (Figures 
5.1 and 5.2). The spectrophotometric method showed 78% uptake of 125 µM CY 
compared to <33 % for the other flavonoids. The HPLC measurements in the 
mitochondrial pellets showed 67% uptake of 125 µM CY compared to <19 % for the 
other flavonoids. In addition, both methods indicated there was a much lower uptake of 
C3G compared to CY (p<0.05). Also with quercetin the spectrophotometric results 
showed significantly (p<0.05) and the HPLC results showed a tendency (p=0.076) 
towards lower absorption of Q3G compared to its aglycone QU. The absorption of C3G 
was not significantly different from Q3G as determined by both measurement 
techniques.  
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Figure 5.1  Spectrophotometric analysis of mitochondrial flavonoid uptake. 
Percent (%) uptake of flavonoids (125 µM) by RLM (1 mg protein) was determined in 
1 mL sucrose-HEPES buffer (pH 7.2) incubated at room temperature in the presence 
and absence of a respiratory substrate (succinate), and an uncoupler (CCCP). The 
control was the flavonoids incubated with fresh RLM in the absence of other additions. 
The amount of flavonoid remaining in the buffer was measured by the spectrometric 
method in RLM supernatants after centrifugation. Shown are the results from samples 
treated with BSA prior to centrifugation. Representative scans of the medium before 
incubation with RLM and after centrifugation are shown in Appendix A. Results are 
expressed as means ± SEM (n=3 mitochondrial preparations), with each experiment 
performed in triplicate.   
ab 
Bars with the same letters indicate no significant difference at p<0.05 . 
Different letters show significant differences between flavonoids at p<0.05. 
* Significantly different from the corresponding control without succinate. p <0.05; 
# 
 
Significantly different from the corresponding condition without CCCP. p<0.05. 
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Figure 5.2 HPLC analysis of mitochondrial flavonoid uptake. Percent (%) uptake of 
flavonoids (125µM) by RLM (1 mg protein) was determined in1 mL sucrose-HEPES 
buffer (pH 7.2) incubated at room temperature in the presence and absence of a 
respiratory substrate (succinate), and an uncoupler (CCCP). The control was the 
flavonoids incubated with fresh RLM in the absence of other additions. The amount of 
flavonoid remaining in the buffer was measured by the HPLC method in RLM pellets 
after being treated with BSA and centrifuged. Results are expressed as means ± SEM 
(n=3 mitochondrial preparations), with each experiment performed in triplicate.   
ab
Bars with the same letters indicate no significant difference at p<0.05 . 
 Different letters show significant differences between flavonoids at p<0.05. 
#
 
 Significantly different from the corresponding condition without CCCP. p<0.05. 
For simplicity, the detailed statistical results of flavonoids with succinate and/or 
CCCP are not shown in the graphs. However, with CCCP or succinate present, not only 
was CY uptake significantly higher than C3G, but QU uptake was significantly higher 
than Q3G (p <0.05). 
With regard to the effects of the respiratory uncoupler (CCCP), only with CY did 
CCCP give significant differences observed, inhibiting uptake by 31.31-46.23 % in the 
presence or absence of succinate (Figures 5.1 and 5.2). With regard to the effect of 
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substrate (succinate), no significant differences were found with succinate compared to 
the condition without succinate except for a significant slight effect on Q3G uptake 
measured by the spectrophotometric method (Figure 5.1).  
After incubations of RLM with flavonoids, centrifugations were conducted in the 
presence and absence of BSA to determine how tightly the flavonoids were bound or 
taken up. No statistically significant differences were observed between the presence 
and absence of BSA for any of the four flavonoids (Figure 5.3). 
 
Figure 5.3 Resistance of mitochondrial bound/uptaken flavonoids to removal by 
BSA. Percent (%) uptake of flavonoids (125 µM) by RLM (1 mg protein) was 
measured by the HPLC method. Experiments were conducted in 1mL sucrose-HEPES 
buffer in the presence and absence of a respiratory substrate (succinate), and an 
uncoupler (CCCP) and were compared between with BSA and without BSA added 
before centrifugation. The control was the flavonoids incubated with fresh RLM in the 
absent of other additions.     
Results are expressed as means ± SEM (n=3 mitochondrial preparations), with each 
experiment performed in triplicate. There were no significant differences (p<0.05) 
observed between treatments with and without BSA for the four flavonoids. 
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5.1.2 Flavonoid effects on mitochondrial respiration 
Fresh RLM were examined for their oxygen consumption response to the four 
flavonoids and ADP (Table 5.1). After adding ADP to the reaction medium, the oxygen 
consumption increased to 4-5 times that of the control, which indicated the RLM used 
in the test were active and well functional. The respiratory control test was performed 
for each mitochondrial preparation in order to confirm the mitochondrial integrity. 
Measurements of the effects of 125 µM flavonoids on state 4 respirations did not show 
any significant effects.  
Table 5.1 Respiratory parameters of mitochondria treated with ADP or 
flavonoids. Fresh RLM (1 mg protein) were examined for their oxygen consumption 
response to the flavonoids (125 µM) and ADP (250 nmol) in 1 mL respiratory buffer 
(125 mM sucrose, 65 mM KCl, 10 mM HEPES, 2 mM KH2PO4/K2HPO4, 1 mM 
MgCl2, pH 7.2), with succinate (5mM) and respiratory cocktail (5 mM each of malate, 
glutamate, pyruvate and α-ketoglutarate) as substrates. The control was the fresh RLM 
in the absent of other additions. Results are expressed  as means ± SEM (n=2 
mitochondrial preparations), with each experiment performed in duplicate.   
Rates were not significantly different from the control at p<0.05 (except ADP 
treatment). 
 
 
 
 
 
 
 
5.1.3 Protective effects of select flavonoids on antimycin-stimulated mitochondrial 
ROS generation 
The ROS generation measurements were calculated as fluorescence units per mg 
mitochondrial protein, and expressed as percentage of the antimycin-stimulated 
Test conditions 
Oxygen consumption rate (nmol O2/ min) 
Control 14.54±0.58 
ADP 68.01±5.33 
CY 18.32±0.81 
C3G 14.70±0.66 
QU 18.74±0.26 
Q3G 19.78±0.22 
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condition, which was marked as the100% value. The antimycin-stimulated ROS 
generation level was 724± 132 fluorescence units per mg mitochondrial protein in the  
directly-incubated (ie. not previously incubated in the preloading condition) RLM, and 
2806 ± 193 fluorescence units per mg mitochondrial protein, in the preincubated and 
reharvested condition.  
Results showed that RLM incubated or preloaded with each of the four flavonoids 
significantly decreased antimycin-stimulated ROS generation (to < 29% and < 56%, 
respectively); and at similar amounts, during respiration (p<0.05) (Figure 5.4). 
Although not as effective as adding flavanoids (125 µM) to the incubations; preloading 
flavonoids inhibited antimycin-stimulated ROS generation to a level less than the 
controls (without antimycin). When incubated together with RLM, CY showed a 
slightly lesser effect on the ROS generation than other flavonoids (p<0.05). Whereas, 
preloaded CY was found to be the most protective (albeit not statistically significant) 
treatment. 
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Figure 5.4 Effects of incubation with flavonoids or pre-loading of flavonoids on 
antimycin-stimulated mitochondrial ROS generation. Mitochondrial ROS 
generation was measured during incubation with respiratory substrates in two test 
conditions: RLM incubated with added flavonoids, and RLM with flavonoids-
preloaded from the experiments shown in Figures 5.1 and 5.2. Flavonoids (125 µM) 
incubated with RLM (1 mg/mL of protein) or flavonoid-preloaded RLM (1 mg/mL of 
protein) were incubated in 500 µL of respiration buffer with 2.5 mM succinate and 2.5 
mM substrate cocktail, 3 µM antimycin (An) and 5 µM DCFDA at 30°C for 30 min. 
Results are expressed as means ± SEM (n=3 mitochondrial preparations), with each 
experiment performed in triplicate.   
* Significantly different from the corresponding antimycin-stimulated condition. p 
<0.05; 
ab 
 
Different letters show significant differences between flavonoids at p<0.05. 
5.1.4 Flavonoids effects on lipid peroxidation  
The susceptibility of RLM to lipid peroxidation induced by t-buOOH was 
determined by the TBARS assay (Figure 5.5). The mitochondria-only and  t-buOOH-
induced TBARS levels were 0.65 ± 0.03 nmol and 2.19 ± 0.04 nmol MDA 
equivalents/mg mitochondrial protein in the directly-incubated (ie. not previously 
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incubated in the preloading condition) RLM, and 0.17 ± 0.001 nmol and 1.45 ± 0.08 
nmol MDA equivalents/mg mitochondrial protein in the preincubated and reharvested 
condition. The results are expressed as percentage of the t-buOOH-induced TBARS 
condition.  
 
Figure 5.5 t-buOOH-induced TBARS formation for mitochondria incubated or 
preloaded with flavonoids (125 µM). Mitochondrial lipid peroxidations were 
measured during incubation with t-buOOH (tbuOOH) in two test conditions: RLM 
incubated with 125 µM added flavonoids and RLM with flavonoids-preloaded (from 
the experiments shown in Figures 5.1 and 5.2). The RLM (at 1 mg/mL of protein) were 
incubated in 50 mM potassium phosphate buffer (pH 7.2) with 1 mM t-buOOH at 37°C 
for 60 min, after which the formation of TBARS was assayed. Results are expressed as 
means ± SEM (n=3 mitochondrial preparations), with each experiment performed in 
triplicate.   
* Significantly different from the corresponding t-buOOH condition. p <0.05. 
ab 
 
Different letters show significant differences between flavonoids at p<0.05. 
When incubated with RLM, each of the four flavonoids (125 µM) almost 
completely inhibited t-buOOH-induced lipid peroxidation (TBARS formation). With 
preloaded flavonoids, the aglycone flavonoids (CY and QU) gave better protection 
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compared to their glucoside (p <0.05) (Figure 5.5), which coincided with greater 
loading (Figures 5.1 and 5.2). 
5.2 In vivo study 
5.2.1 Flavonoids distribution in plasma, tissues and mitochondria  
5.2.1.1 Flavonoids distribution in plasma 
In plasma 30 min after administration, the concentration of QU was found to be 
similar to its glucoside and was significantly higher than CY and C3G (p<0.05) (Figure 
5.6). The results indicated that the flavonols remained more in plasma than the 
anthocyanins, and both flavonoids presented to an equal extent with their glucosides.  
 
Figure 5.6 Distribution of flavonoids in plasma. CY, QU and their 3-glucosides were 
administered into rat tail vein to give a dose of 7.6 µmol/Kg body weight. After 30 min, 
a blood sample was collected from the heart under anesthesia into heparin-containing 
tubes, and centrifuged at 4000 g for 8 min at 4°C in order to collect the plasma. 
Concentrations of the flavonoids in plasma were measured by HPLC with photodiode 
array detection. Results are expressed as means ± SEM (n=5 animals), with each HPLC 
measurement performed in duplicate.   
ab 
Bars with the same letters indicate no significant difference at p<0.05. 
Different letters show significant differences between flavonoids  at p<0.05. 
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5.2.1.2 Flavonoids distribution in tissues 
Figure 5.7 shows the amounts of the different flavonoids detected in liver, kidney, 
heart, and brain 30 min after administration into the tail vein of rats. The amount of CY 
per g tissue weigh was > 23% higher than the other flavonoids in all evaluated organs. 
The level of C3G also tended to be higher than QU and Q3G in kidney, although it was 
not statistically significant (p=0.16 and 0.0625 respectively). In some cases such as the 
levels of the flavonoids in brain and the level of QU in heart, the levels were near the 
limits of detection. 
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Figure 5.7 Distribution of flavonoids in tissues 30 min after intravenous injection. 
CY, QU and their 3-glucosides were administered into rat tail vein to give a dose of 7.6 
µmol/Kg body weight. After 30 min, liver, kidney, heart and brain were removed. 
Concentrations of flavonoids accumulated in tissues were measured by HPLC with 
photodiode array detection. Results are expressed as means ± SEM (n=5 animals), with 
each HPLC measurement performed in duplicate. Representative chromatograms are 
shown in Appendix B.  
ab (liver), cd (kidney), ef (heart), gh (brain) 
Bars with the same letters indicate no significant difference at p<0.05 . 
Different letters show significant differences between 
flavonoids   at p<0.05. 
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Comparing the levels in different organs showed some differences. Due to the 
complexity, the statistical comparisons of the same flavonoid in different organs are 
described here in the results section rather than in the graph. The recovered CY showed 
the highest amount in liver with the lowest in brain (liver > kidney > heart > brain), but 
a statistically significant difference (p <0.05) was found only between liver and brain. 
C3G accumulated to a higher amount in liver and kidney than heart and brain (p 
<0.05). QU was distributed more to liver than other organs, and the differences were 
significant compared to heart and brain contents (p <0.05). Similar results were found 
with Q3G, but it was significantly different only between liver and brain (p <0.05).              
5.2.1.3 Flavonoids distribution into liver mitochondria 
After the dose administration, the distribution of flavonoids to the liver 
mitochondria is shown in Figure 5.8. The concentration of CY recovered in RLM was 
10.68±3.38 pmol/mg protein, which was significantly higher than the other flavonoids 
(p<0.05) (Figure 5.8). No significant difference was found among the other three test 
flavonoids. Although only a few post-mitochondrial supernatant samples were tested, 
no flavonoids were detected in post-mitochondrial supernatants.  
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Figure 5.8 Distribution of flavonoids in liver mitochondria. CY, QU and their 3-
glucosides were administered intravenously into rat tail vein to give a dose of 7.6 
µMol/Kg body weight. Thirty min after administration, mitochondria were immediately 
isolated from half of the liver. Concentrations of flavonoids accumulated in 
mitochondria were measured by HPLC. Results are expressed as means ± SEM (n=5 
animals), with each HPLC measurement performed in duplicate.   
ab 
Bars with the same letters indicate no significant difference at p<0.05. 
Different letters show significant differences between flavonoids   at p<0.05. 
 
5.2.2 Intravenous flavonoid effects on tissues and mitochondrial oxidative stress  
5.2.2.1 Intravenous flavonoid effects on tissue TBARS 
The levels of endogenous TBARS in tissues were determined in order to evaluate 
the effects of intravenous delivery of flavonoids against oxidative stress in the body. 
No flavonoid administration groups showed a significant decrease in TBARS (Figure 
5.9).  
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Figure 5.9 Endogenous TBARS in tissues after intravenous flavonoid treatments. 
CY, QU and their 3-glucosides were administered intravenously into rat tail vein to 
give a dose of 7.6 µmol/Kg body weight. After 30 min, liver, kidney, heart, and brain 
were removed. Tissue (about 50 mg) powders were homogenized in 200 µl RIPA 
buffer (50 mM Tris, 150 mM KCl, 1% Trition X-100, 1% sodium deoxycholate, 0.1% 
EDTA, pH 7.4), and the level of TBARS formation was assayed. Results are expressed 
as means ± SEM (n=5 animals), with each TBARS experiment performed in duplicate.   
In each tissue there were no significant differences from the control group at 
p<0.05. 
 
In liver, QU and Q3G treatments tended to give a decrease in endogenous TBARS, 
but it still was not statistically significant (p=0.2350 and p=0.5377, respectively).  The 
results did indicate that the organs had different degrees of endogenous TBARS, with 
brain showing the lowest level (p<0.05). 
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5.2.2.1 Intravenous flavonoid effects on susceptibility of liver mitochondria to lipid 
peroxidation 
The effect of intravenous delivery of flavonoids on susceptibility of the liver 
mitochondria to lipid peroxidation induced by t-buOOH was determined by the 
TBARS method as described previously (4.3.4). Delivery of the flavonoids at this dose 
did not significantly affect the susceptibility to lipid peroxidation under the conditions 
tested (Figure 5.10). There was no decrease in TBARS formation in all flavonoid 
treatments compared to control group and all experiment groups presented the 
stimulated peroxidation at an equal level.  
 
Figure 5.10 Mitochondria susceptibility to lipid peroxidation induced by t-
buOOH, after intravenous flavonoid treatments. CY, QU and their 3-glucosides 
were administered into rat tail vein to give a dose of 7.6 µmol/Kg body weight. After 
30 min, RLM were immediately isolated from half of the liver. RLM (1 mg/mL of 
protein) were incubated in 50 mM potassium phosphate buffer (pH 7.2) with 1 mM t-
buOOH at 37°C for 60 min, and the formation of TBARS was assayed. Results are 
expressed as means ± SEM (n=5 animals), with each TBARS experiment performed in 
duplicate.   
There were no significant differences from the control group at p<0.05 
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6. DISCUSSION  
Anthocyanins represent one of the major groups of naturally occurring 
flavonoids, and are attracting much attention for preventing diseases because of their 
potent antioxidant abilities and free-radical scavenging activities (de Pascual-Teresa et 
al., 2010; Heim et al., 2002). A number of studies with anthocyanin-rich foods and 
extracts have indicated the tissue distribution of anthocyanins and potential beneficial 
effects in biological systems (Prior & Wu, 2006). However, the biological activities of 
individual anthocyanins have not been as extensively studied as other flavonoids, in 
part because of expense and limited commercial sources. In particular, there are no 
published data reports on the mitochondrial uptake of anthocyanins and their effects on 
mitochondrial functions.  The present thesis investigated cyanidin and cyanidin-3-
glucoside uptake in mitochondria and their protective effects against mitochondrial 
oxidative stress in vitro, as compared to the flavonols quercetin and quercetin-3-
glucoside. The study also investigated in vivo tissue distribution and their accumulation 
in mitochondria after intravenous administration, and effects on susceptibility of 
isolated mitochondria to oxidative stress and on endogenous levels of lipid 
peroxidation products in tissues.   
6.1 The ability of flavonoids to accumulate in mitochondria  
Flavonoid uptake was investigated in isolated rat liver mitochondria. The uptake of 
pure cyanidin and quercetin, and their 3-glucosides into isolated rat liver mitochondria 
were tested with the presence and absence of a respiratory substrate (succinate), as well 
as with an uncoupler (CCCP) to modulate the membrane potential. The strength of 
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uptake/binding was also evaluated by BSA incubation prior to centrifugation to remove 
loosely bound flavonoids. Overall, results indicated that the flavonoid aglycones can 
rapidly and efficiently enter into or cross mitochondrial membranes in a short time 
period, especially cyanidin, thereby leading to a marked mitochondria accumulation of 
the flavonoid (Figure.5.1 and 5.2).  
The HPLC results confirmed spectrometric measurements of mitochondrial 
flavonoid uptake following in vitro exposure. In contrast to the HPLC method, the 
spectrophotometer measurements showed slightly higher levels of uptake. Based on 
greater accuracy of the HPLC method, these results were used for statistical analysis 
and discussion. However, the test flavonoids lost during the sample extraction and 
preparation prior to HPLC injection might be a possible reason that HPLC 
measurements had lower results. 
Previously, anthocyanins have been demonstrated to cross the cell membrane of 
cultured cells and could be detected in the interior of the cells (McGhie & Walton, 
2007), although the mitochondria were not investigated. Evidence also suggests that 
quercetin can efficiently cross the plasma membrane in many mammalian cell types 
and is able to reach the mitochondrial compartment (Fiorani et al., 2006; Johnston et 
al., 2005; Strobel et al., 2005).  
Most recently, the rapid accumulation of quercetin in mitochondria has been 
confirmed (Fiorani et al., 2010). In this study, quercetin accumulated in cells and 
subsequently accumulated in the mitochondria during incubation of Jurkat human T 
lymphoblast cells with 10-100 µM quercetin (Fiorani et al., 2010). The study further 
showed that when 50 µM quercetin was incubated for 10 min with purified cellular 
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mitochondria (0.15 mg protein), mitochondrial quercetin approached the apparent 
concentration of 35 mM (normalized to mitochondrial volumes) (Fiorani et al., 2010). 
The present study presented a similar tendency, with 25% of 125 µM quercetin 
accumulated in rat liver mitochondria (1 mg protein) after 10 min incubation without 
BSA. This result provided more evidence of the ability of quercetin to accumulate in 
mitochondria, employing different test mitochondrial sources.  
Flavonoids have an affinity to bind with albumin (Liu et al., 2010). Only a slight 
non-significant decrease was observed with BSA treatment after incubation with all test 
flavonoids (Figure.5.3). These results imply strong binding or uptake of flavonoids by 
the mitochondria, which may involve hydrogen bonds and hydrophobic interactions 
(Fiorani et al., 2010; Rice-Evans et al., 1996). Flavonoids can accumulate and position 
at the lipid-water interface of membranes through interactions with, and penetration of 
cell membranes (Oteiza et al., 2005).  
Fiorani et al.(2003) suggested that heme-containing protein allows significant 
mitochondrial accumulation of flavonoids, this ability of flavonoids to bind with heme-
containing protein was also concluded by numerous studies on the effects of phase I 
monoxygenase enzyme activities (Moon et al., 2006). Mitochondrial hydrophobic 
membrane and heme-containing protein components may therefore promote 
preferential accumulation of the flavonoid. Supposedly because of these factors 
mitochondria express higher uptake and binding ability with quercetin than does 
cytosol and/or other organelles (Fiorani et al., 2003; Fiorani et al., 2010).  
Chemical structure was found to influence flavonoid accumulation in mitochondria 
in this study. The two aglycones were taken up to a much greater extent that their 3-
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glycoslated derivatives under all test conditions (Figure.5.2). Larger molecular size and 
hydrophilicity of the glucosides make them more difficult to pass through the 
membrane of mitochondria.  
6.2 Anthocyanin accumulation in mitochondria 
 It was conceivable that anthocyanins and especially anthocyanidins could exhibit 
appreciable uptake into mitochondria, because they have similar features with TPP 
cation in being able to bear a positive charge and being lipophilic. Such lipophilic 
cations accumulate substantially within mitochondria owing to its membrane 
lipophilicity and  potential (Ross et al., 2005). Mitochondrial accumulation of CY was 
impressive since approximately 67-78% of the initial concentration was recovered in 
mitochondria after 10 min of incubation. The CY content was confirmed to be 
significantly higher (3.5 fold) than QU (Figure 5.2.).  This finding provided evidence 
that the anthocyanidin CY rapidly penetrates the mitochondrial membrane and 
eventually accumulates in mitochondria.  
 We also found that CCCP significantly decreased the CY content after loading, 
unlike with the other flavonoids. This evidence suggests that the electrical potential of 
the mitochondrial membrane is involved in anthocyanidin accumulation to some extent. 
The large membrane potential (150– 180 mV) across the mitochondrial inner 
membrane (negative inside) encourages delivery of these molecules to mitochondria, 
along with the lipophilic character. However, experimental results did not show an 
increased accumulation of CY when succinate added to the incubation medium. The 
reason for this is unclear, but the effect of CCCP in the absence of succinate suggests 
that the mitochondria had a membrane potential due to endogenous substrates (state 1 
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respiration). In the presence of succinate, CCCP also significantly decreased the CY 
content, to a level lower than with only CCCP present. The mechanism is not clear, so 
further investigation is still needed.   
 Furthermore, the uptake of C3G was significantly lower than CY (5% of 125 µM), 
indicating that the hydrophobicity and mass of the molecule are related with 
accumulation. Addition of CCCP did not have effect on C3G uptake as it did with CY, 
suggesting that the presence of a glucose moiety may have a stronger influence on 
anthocyanins accumulation. Apparently, the presence of a sugar residue affects the 
physicochemical properties of the molecule and thus their ability to cross membranes. 
Unlike with CY, the CCCP uncoupling affected only slightly (not statistically 
significant) the flavonol QU uptake, indicating that the membrane potential may not 
have much influence this process; thus passive diffusion may be the major route of 
quercetin accumulation in mitochondria. The difference in effect of CCCP (i.e. 
decrease in membrane potential) on uptake is likely due to a difference in charge of the 
flavonoid. At the more acidic pH of the mitochondrial membrane surface, quercetin 
with a pKa of ~7 (Lemanska et al., 2001) would be a mixture of neutral molecules and 
anions, while cyanidin, with a pKa of 5.5 for the cation (Borkowski et al., 2005), would 
be a mixture of the neutral quinoid form with the flavylium cation. The chemical 
property of being more positively charged at physiological pH may be an advantage of 
anthocyanidins/anthocyanins that leads to uptake being driven to some extent by the 
mitochondrial membrane potential.   
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6.3 Effects on mitochondrial respiration 
The flavonoids did not have significant effects on mitochondrial oxygen 
consumption, with succinate or with NADH-producing substrates. These results 
indicated that the flavonoids did not have strong uncoupling effects, and did not inhibit 
complex 1 (NADH dehydrogenase) or complex 2 (succinate dehydrogenase) activities. 
However, the results of  Trumbeckaite et al. (2006) suggested that flavonoids possess 
uncoupling activity in a dose-dependent manner, where the maximal (100%) 
stimulation of the State 4 respiration was obtained at 1.08 ng/mL (3.6 nM) of quercetin 
with pyruvate + malate as substrates, but higher concentrations of flavonoids resulted 
in a drop of uncoupled respiration.  In the current study, exposure of mitochondria 
during state 4 respiration to either 125 µM CY or QU non-significantly increased 
oxygen consumption rates 26% and 29%, respectively. Considering the results of 
Trumbeckaite et al. (2006), the concentration of flavonoids in the current study may 
have been above that where significant uncoupling would be observed. More recently, 
Trumbeckaite et al.(2012) reported that the anthocyanins, malvidin-3-glucoside, 
malvidin-3-galactoside, and cyanidin-3-galactoside at ~50 nM had no effects on rat 
heart mitochondrial respiration with pyruvate plus malate.  
6.4 The effects of flavonoids on mitochondrial oxidative damage 
6.4.1 Antioxidant ability of flavonoids incubated together with mitochondria 
The impacts of flavonoids on mitochondrial oxidative stress were evaluated by ROS 
generation and TBARS formation measurements.  
The effects of the different flavonoids were compared at equimolar concentration on 
antimycin-stimulated ROS generation during mitochondrial respiration. Consistent with 
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their known effects on mitochondrial ROS generation (Cadenas and Davies 2000) 
antimycin stimulated ROS generation by 39%, while CCCP decreased ROS generation 
by 34%. Cyanidin, quercetin and their 3-glucosides all strongly inhibited antimycin 
stimulated ROS generation (Figure 5.4). The flavonoids all inhibited ROS generation 
and/or accumulation to levels well below that in the presence of CCCP. The flavonoids 
may have either modulated ROS generation or effectively scavenged ROS, or worked 
both ways. Additionally, when added at equimolar concentrations QU showed a 
significantly stronger effect on ROS generation than CY, which may have been due to 
QU being a very efficient radical scavenger (Rice-Evans et al., 1996) or due to an 
effect on the generation of ROS by the respiratory chain. However, in the preloading 
experiments, CY gained a greater effect on ROS generation due to greater 
accumulation. 
When added externally to RLM, CY showed a significant lowering effect on ROS 
generation when compared to C3G. This finding leads to the hypothesis that although 
less C3G than CY is taken up by mitochondria, C3G might be an efficient antioxidant 
in cells against oxidative damage caused by mitochondrial release of ROS.   
Similar effects of flavonoids on ROS generation in the presence of antimycin were 
also reported most recently (Lagoa et al., 2011). With much lower concentrations of 
flavonoids than were used in this study, although also with a much lower concentration 
of mitochondria (0.1 mg protein/mL), quercetin effectively inhibited (IC50≈1–2 µM) 
H2O2 production stimulated by rotenone and antimycin in rat heart and brain 
mitochondria. Also, the study found that 10 µM quercetin decreased the state 3 
(absence of antimycin) H2O2 production rate in rat heart mitochondria (0.1 mg/mL 
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protein) to 30% and in brain mitochondria (0.1 mg/mL protein) to <10%. However this 
study failed in showing the effect of cyanidin because of direct interference with the 
Amplex Red/peroxidase detection method.   
The four flavonoids were also compared for their ability to inhibit t-buOOH-induced 
mitochondrial lipid peroxidation. All test flavonoids significantly suppressed the t-
buOOH inducted lipid peroxidation to a similar extent (Figure 5.4), confirming that 
these flavonoids and their 3-glucosides were powerful chain-breaking antioxidants that 
protect membranes from oxidative damage (Oteiza et al., 2005).  
In addition, besides free radical scavenging ability, the hydroxyl moieties of the B 
and C rings allow good metal chelation ability (Welch et al., 2008).  Low molecular 
weight Fe2+
Valko et al., 2006
 complexes exist in mitochondria and are capable of catalyzing 
mitochondrial membrane lipid peroxidation ( ). 
 Flavonoids have previously shown protective effects against mitochondrial lipid 
peroxidation.  Experiments on isolated rat liver mitochondria indicated that quercetin 
had strong potency (IC50
Santos et al., 1998
=30 µM) in inhibiting ADP/Fe(II)-induced lipid peroxidation 
( ). Our results support previous observations that flavonols, 
anthocyanins and anthocyanin aglycones are effective at inhibiting transition metal-
catalyzed lipid membrane peroxidation (Soczynska-Kordala et al., 2001).  
Anthocyanins have previously shown protection against peroxidation in other lipid 
systems. Wang et al. (1999) reported that cyanidin and three cyanidin glycosides 
inhibited lipid peroxidation of a liposome system by 39% to 75%, consistent with 
results in our study. Tsuda et al., (1994) reported that cyanidin had a stronger effect 
than C3G in preventing lipid peroxidation induced by active oxygen radicals in 
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liposomes (linoleic acid autoxidation) and rabbit erythrocyte membranes. According to 
these results, glycosylation with carbohydrate units at the C3 position decreases 
antioxidant ability. However this observation was not confirmed in the current study.  
There still is limited information on antioxidant activities and free radical 
scavenging properties of anthocyanins compared to studies of other flavonoids. 
Overall, this study provided evidence that anthocyanins might have similar protection 
effects as flavonols against oxidative lipid damage, although at the concentration 
employed (125 µM) the t-buOOH-induced TBARS formation was completely blocked 
by all flavonoids.  
6.4.2 Bio-antioxidant ability of flavonoids after accumulation in mitochondria  
When mitochondria were incubated together with added flavonoids (discussed 
above), the impact of evaluated flavonoids on induced mitochondrial ROS and 
oxidative damage was suppressed to a similar extent. But the whole protective effect 
was partly contributed by flavonoids which were not taken up in mitochondria and 
present in the medium. Our results demonstrate that some flavonoids can accumulate in 
mitochondria to a remarkable amount in a short time. It is important to know the extent 
that the mitochondria preloaded flavonoids could display biological activity and protect 
mitochondria from oxidative damage. The test on flavonoid- preloaded mitochondria 
may be a more relevant expression to the antioxidant ability of the flavonoids in the 
biological system.  
Flavonoids preloaded into mitochondria were successful in protecting against 
induced ROS and oxidative damage. Accumulated flavonoids in mitochondria 
effectively modulated/interfered with induced ROS generation and lipid peroxidation 
 77 
 7
7 
   
   
 
(Figures 5.4 and 5.5); with CY and QU showing the strongest activities. The preloaded 
flavonoid glucosides, especially C3G, gave less protection than the aglycones, which 
was consistent with the observation that the glucosides had less accumulation in 
mitochondria. Part of this difference may be that substitution of hydroxyl groups by 
glycosylation decreases the antioxidant activity (Havsteen, 2002; Rice-Evans et al., 
1996; Wang et al., 1999), and may influence the antioxidant capacity of flavonoids in 
lipid oxidation systems. However glycosylation also influences the 
lipophilicity/hydrophilicity and decreased their mitochondrial uptake, which would 
decrease their effect on membrane lipid peroxidation.  
The measurement of ROS generation by mitochondria with flavonoids preloaded 
showed CY to be the most protective, although with similar protective effects by QU. 
While the stronger protection by CY reflects its higher concentration (i.e. uptake) in the 
mitochondria and its strong free radical scavenging properties, the almost equal 
protection by QU despite less being present suggests that QU is more potent at 
lowering ROS levels. Similar TBARS formation suppression was also observed in CY 
and QU preloaded mitochondria, supporting the greater potency of QU against 
oxidative damage.         
Preloaded flavonoid glucosides, which showed a lower level of mitochondrial 
accumulation, seemed to moderate ROS generation to a similar level as their preloaded 
aglycones. Considering the lower uptake, the flavonoid glycosides may display 
stronger biological activities against ROS generation. However, their mechanism of 
this impact is not clear, possible actions are effects on the mitochondrial electron 
transport chain and scavenging generated ROS. Further investigation is still needed.  
 78 
 7
8 
   
   
 
Overall, the in vitro study demonstrated that cyanidin can rapidly accumulate in 
mitochondria which was postulated to be due in part to its unique chemical structure. 
The test flavonoids accumulated in mitochondria exhibited significant antioxidant 
ability in the presence of oxidative stress. Mitochondria are a critical source of ROS 
generation, so their ability to accumulate a significant amount of cyanidin suggests that 
cyanidin could be potential mitochondria protective compound against oxidative 
damage in physiological systems. 
6.5 Flavonoids distribution in tissues, mitochondria and plasma in vivo  
Several studies employing fruit extracts have demonstrated that anthocyanins are 
rapidly absorbed and distributed in the blood and tissues (Table 2.2). So far, some 
studies suggest the core phenolic aglycones and conjugated sugar moieties can 
influence the absorption of anthocyanins (Ichiyanagi et al., 2006; Kalt et al., 2008; Wu 
et al., 2005), but no investigations have been performed comparing anthocyanin 
glycones and aglycones as well as comparing anthocyanins to other flavonoids.  
Our results provide evidence that the pure anthocyanidin and it glucoside have a 
greater ability to accumulate in organs, especially liver and kidney, than the analogous 
flavonols (Figure 5.5). In liver, the content of CY was significantly higher (2.85 nmol/g 
tissue weight) than QU (0.77 nmol/g) and Q3G (0.85 nmol/g) (p <0.05). Similarly, 
anthocyanin distribution in the kidney with C3G of 2.03 nmol/g and CY of 2.50 
nmol/g, was higher than that of QU and Q3U (<0.38 nmol/g).  These results were 
higher than the results of Ichiyanagi et al. (2006), who reported total anthocyanins of 
0.14 nmol/g and 0.46 nmol/g in liver and kidney tissue, respectively, 15 min after 
intravenous administration of a 5 mg bilberry extract (equal to a dose of 11.1 µmol/Kg 
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body weight anthocyanins, which was slightly higher than our dose of 7.6 µmol/Kg 
body weight. The used anthocyanins source and administration time were possibilities 
for the differences in tissues distribution 
The CY and C3G levels in plasma of 0.61 and 0.68 µmol/L were lower than those of 
QU and Q3G (1.88 and 1.69 µM/L) 30 min after intravenous delivery, suggesting more 
rapid clearance and/or tissue uptake of the anthocyanins. These results with the 
anthocyanins were slightly higher than but similar to those of Matsumoto et al. (2006a) 
who reported a Cmax of 0.285 µmol/L and Tmax
Quantitative comparisons of tissue distribution also indicated the higher amount of 
CY than C3G with the same dose administration. Glycosylation influences both the 
molecular size and lipophilicity of anthocyanins; and thus influences their ability to be 
taken up by, and enter into tissue cells.  
 of 26.3 min in plasma after the same 
intravenous dose of delphinidin-3-rutinoside from blackcurrant extract. 
Compared to brain, CY and C3G accumulated to a significantly higher amount in 
liver tissue. These findings among tissues are consistent with anthocyanin and 
anthocyanidin absorption, metabolism and retention among tissues and factors that 
delay distribution such as the blood-brain barrier and the blood-retinal barrier (Kalt et 
al., 2008). A similar observation was also found for QU and Q3G, which QU 
distributed more in liver than other organs, and significant differences were found 
compared to heart and brain contents. Clearly, these results show that the flavonoid 
accumulation is tissue dependent.   
As was noted, CY and to a lesser extent C3G is more effectively accumulated in 
tissues than the flavonols. In addition, CY accumulated more in mitochondria than the 
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flavonols, consistent with the in vitro results. These findings demonstrated that 
cyanidin was associated with tissue cells and accumulated even further in mitochondria 
in vivo because of its unique chemical structure properties. The relatively lower 
concentration of QU in tissues and mitochondria and higher plasma concentration also 
indicates cyanidin is more rapidly taken up into mitochondria. 
However, there are some concerns in the present study. Firstly, as discussed in 5.2.3, 
the recovery rate of the tissue extraction recovery method is not satisfying. The 
anthocyanins recovery from liver was 57 ± 19%, and from kidney was 89± 13% in Kalt 
et al.’s study (Kalt et al., 2008), which used a modified extraction method from the 
Tsuda group (Tsuda et al., 1999b). Whereas, with different extraction procedures and 
solvents used, our flavonoid tissue recovery was only about 23%-40%, the 
concentration in tissues might be substantially underestimated. Also, Kalt et al. (2008) 
reported that freeze drying and storage -80 °C causes anthocyanin losses. Therefore the 
sample extraction methods may not have been ideal to detect such low content of 
flavonoids. In addition, the flavonoid distribution in vivo was low, and the test sample 
concentration of some flavonoids (QU and Q3G) were actually close to the HPLC limit 
of quantification range (Appendix B) , especially in the measurements from 
mitochondria. Thus, in order to confirm these results, future studies with a better 
sample preparation method are required. Nevertheless the levels of CY in tissues and 
mitochondria were high enough to be readily measured, and showed the relatively 
higher accumulation compared to the other flavonoids. 
 81 
 8
1 
   
   
 
6.6 Considerations of results analysis in the in vivo study 
Although flavonoid recovery from RLM (both in vivo and in vitro) were >86%, the 
extraction recovery of the flavonoids for tissues were <40% (Appendix Table B.1), so 
the tissue concentrations might be substantially underestimated. Also, the HPLC 
column was regenerated and not very efficient. Therefore, the responding spectral peak 
area of some of the flavonoids were close to or lower than the HPLC limit of 
quantification range, especially during mitochondria measurements after in vivo 
treatments (except for CY). No correction was made in the results for losses during 
sample extraction. To confirm these results, future studies with a better sample 
preparation method are required. 
6.7 Flavonoid effects on tissues and mitochondrial oxidative stress 
We also tested the extent to which the intravenous delivery of flavonoids protected 
the tissues and mitochondria from oxidative damage. A few studies have documented 
anthocyanins administration effects on cell and tissues oxidative stress. The oral 
administration of an anthocyanin-rich extract prevented hypertension, cardiac 
hypertrophy and production of ROS, and expression of NADPH oxidase in rats 
maintained on a high-fructose diet (Al-Awwadi et al., 2005). In a study on in vivo 
antioxidant activity of C3G by using hepatic ischemia/ reperfusion (I/R) injury as a 
model of oxidative stress, the C3G oral administration significantly suppressed rat liver 
damage caused by increased oxidative stress (Tsuda et al., 1999a). In this perspective, 
anthocyanins administration, which our results show subsequently accumulate in 
tissues and further in mitochondria, can sufficiently increase antioxidant capacity of 
tissues against oxidative damage.   
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In the current study with intravenous injection of flavonoids to rats, it indicated the 
lack of significant protection effect of flavonoid administration on tissue endogenous 
oxidative stress. This is probably due to low flavonoid content achieved in this 
protocol. Also, the results failed to support the initial hypothesis, there were no effects 
on endogenous TBARS after 30 min administration. Another approach might be to test 
for susceptibility to TBARS formation in order to evaluate the flavonoid effects on 
tissues oxidative stress. Susceptibility to TBARS formation could not be tested in the 
current homogenates in RIPA buffer due to the presence of EDTA, which would inhibit 
metal-catalyzed lipid peroxidation. 
Moreover, our results indicated that organs had different degrees of endogenous 
lipid peroxidation, with brain showing the lowest level. The mechanism of such tissue 
dependent TBARS levels is not clear yet.    
With mitochondria, intravenous delivery of flavonoids did not affect mitochondrial 
susceptibility to lipid peroxidation (Figure 5.8). Considering the low amount of 
flavonoids accumulated in mitochondria after delivery, it might not have sufficient 
effect against oxidative stress to be observed in experiments with this single dose 
administered intravenously. Another possibility for this unexpected result may be the 
quite high t-buOOH used, which may have overwhelmed the loaded flavonoids. The 
test methods need to be modified in order to give better future determinations.   
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7. CONCLUSIONS AND PERSPECTIVE  
Anthocyanins such as cyanidin are an important class of flavonoid and abundant in 
the diet. The present study provides evidence that cyanidin acts as a mitochondrial 
targeted antioxidant and, thereby, exhibits protective effects. Cyanidin can rapidly and 
efficiently cross mitochondrial membranes in a short time period, leading to a 
remarkable mitochondria accumulation. With regards to the antioxidative mechanism 
of anthocyanins, the results suggest that while anthocyanidins such as cyanidin 
accumulate in mitochondria, they exhibit strong bio-antioxidant activity against 
oxidative stress. Also, the presence of sugar residues affects the physico-chemical 
properties of the molecule and thus their ability to cross membranes and enter 
mitochondria. According to these results, cyanidin could be a potent natural antioxidant 
compound that is effective in mitochondria-protective therapies. 
The in vivo study indicates that the anthocyanidin and its glucoside have greater 
ability than flavonols to accumulate in organs; especially liver and kidney. Also, the 
results indicated cyanidin distributed more in mitochondria than the other flavonoids 
and consistent with in vitro results was present in mitochondria to a much greater 
extent than its glycoside. 
Perhaps because of low concentration, a single intravenous cyanidin administration 
resulted in no statistically significant protection on tissue oxidative stress. Also with 
mitochondria, no significant effects of flavonoids delivery were found in susceptibility 
to lipid peroxidation induced by t-buOOH due to the low concentration.  
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In conclusion, with emphasis to the mitochondrial antioxidant activity of 
anthocyanins, cyanidins as dietary compounds have potential beneficial effects on 
human health and can apply in numerous disease conditions. The mitochondrial 
targeted protective properties of cyanidin suggest that anthocyanidins are of possible 
therapeutic use in mitochondria diseases. 
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8. FUTURE DIRECTIONS  
My thesis indicated the ability of CY to accumulate in mitochondria; more studies 
are still needed to determine the mechanisms of this action. CY showed a significant 
slightly lowering effect on ROS generation than C3G and QU, but with similar effects 
as the other flavonoids against lipid peroxidation.  Further investigation might need to 
establish the individual anthocyanins antioxidant properties in different types of 
oxidative damage. Structure-activity relationships need further investigations.   
Further studies are needed to complete the quantification of flavonoids in tissues, 
cells and mitochondria using more suitable analysis methods. A more specific method 
to extract flavonoids from tissue samples is needed. 
In the current in vivo study, we learned about flavonoid distribution in plasma, 
tissues and mitochondria with single dose of administration. It will be important to 
measure with higher doses and different time periods after administration. Also, the 
tissue and mitochondria distribution investigation would need to be extended to 
different delivery methods including oral, gavage and dietary. Data on long term 
administration and different doses of delivery are needed.  
The protective effects of flavonoids in tissues and mitochondrial oxidative damage 
were not observed in this study. The low dose administration with consequently low 
distribution into mitochondria is one possible explanation. A higher or multiple dose 
protocol might lead to greater flavonoids accumulation and exhibit expected effects. 
Alternatively, a more gentle stress should be employed, such as incubation in air 
(instead of with 5 mM t-buOOH) might be needed to reveal protective effects. 
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To further reveal the flavonoids effects on oxidative stress, a long term dietary 
administration investigation would be important and with different doses and time 
period of treatment as well as other delivery protocols.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 87 
 8
7 
   
   
 
 
 
9. REFERENCES 
Akhlaghi, M., & Bandy, B. (2009). Mechanisms of flavonoid protection against 
myocardial ischemia-reperfusion injury. J Mol Cell Cardiol, 46(3), 309-317. 
Al-Awwadi, N. A., Araiz, C., Bornet, A., Delbosc, S., Cristol, J. P., Linck, N., Azay, J., 
Teissedre, P. L., & Cros, G. (2005). Extracts enriched in different polyphenolic 
families normalize increased cardiac NADPH oxidase expression while having 
differential effects on insulin resistance, hypertension, and cardiac hypertrophy 
in high-fructose-fed rats. J Agric Food Chem, 53(1), 151-157. 
Ali, A. A., Velasquez, M. T., Hansen, C. T., Mohamed, A. I., & Bhathena, S. J. (2005). 
Modulation of carbohydrate metabolism and peptide hormones by soybean 
isoflavones and probiotics in obesity and diabetes. J Nutr Biochem, 16(11), 693-
699. 
Andres-Lacueva, C., Shukitt-Hale, B., Galli, R., Jauregui, O., Lamuela-Raventos, R., & 
Joseph, J. (2005). Anthocyanins in aged blueberry-fed rats are found centrally 
and may enhance memory. Nutr Neurosci, 8(2), 111-120. 
Armstrong, J. S. (2007). Mitochondrial medicine: pharmacological targeting of 
mitochondria in disease. Br J Pharmacol, 151(8), 1154-1165. 
Armstrong, J. S. (2008). Mitochondria-directed therapeutics. Antioxid Redox Signal, 
10(3), 575-578. 
Aruoma, O. I. (2003). Methodological considerations for characterizing potential 
antioxidant actions of bioactive components in plant foods. Mutat Res, 523-524, 
9-20. 
Ashok, B. T., & Ali, R. (1999). The aging paradox: free radical theory of aging. Exp 
Gerontol, 34(3), 293-303. 
Avery, S. V. (2011). Molecular targets of oxidative stress. Biochem J, 434(2), 201-210. 
Aviram, M. (2000). Review of human studies on oxidative damage and antioxidant 
protection related to cardiovascular diseases. Free Radic Res, 33 Suppl, S85-97. 
Bandy, B., & Davison, A. J. (1990). Mitochondrial mutations may increase oxidative 
stress: implications for carcinogenesis and aging? Free Radic Biol Med, 8(6), 
523-539. 
Bandy, B., & Bechara, E. J. (2001). Bioflavonoid rescue of ascorbate at a membrane 
interface. J Bioenerg Biomembr, 33(4), 269-277. 
Bazzano, L., Serdula, M., & Liu, S. (2003). Dietary intake of fruits and vegetables and 
risk of cardiovascular disease. Curr Atheroscler Rep, 5(6), 492-499. 
Beecher, G. R. (2003). Overview of dietary flavonoids: nomenclature, occurrence and 
intake. J Nutr, 133(10), 3248S-3254S. 
Borkowski, T., Szymusiak, H., Gliszczynska-Rwiglo, A., Rietjens, I. M., & 
Tyrakowska, B. (2005). Radical scavenging capacity of wine anthocyanins is 
strongly pH-dependent. J Agric Food Chem, 53(14), 5526-5534. 
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S. S. (2004). 
Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell 
Physiol, 287(4), C817-833. 
 88 
 8
8 
   
   
 
Bub, A., Watzl, B., Heeb, D., Rechkemmer, G., & Briviba, K. (2001). Malvidin-3-
glucoside bioavailability in humans after ingestion of red wine, dealcoholized 
red wine and red grape juice. Eur J Nutr, 40(3), 113-120. 
Cadenas, E., & Sies, H. (1998). The lag phase. Free Radic Res, 28(6), 601-609. 
Cadenas, E., & Davies, K. J. (2000). Mitochondrial free radical generation, oxidative 
stress, and aging. Free Radic Biol Med, 29(3-4), 222-230. 
Cao, G., & Prior, R. L. (1999). Anthocyanins are detected in human plasma after oral 
administration of an elderberry extract. Clin Chem, 45(4), 574-576. 
Cavallini, L., Bindoli, A., & Siliprandi, N. (1978). Comparative evaluation of 
antiperoxidative action of silymarin and other flavonoids. Pharmacol Res 
Comm, 10(2), 133-136. 
Chen, P. N., Chu, S. C., Chiou, H. L., Chiang, C. L., Yang, S. F., & Hsieh, Y. S. 
(2005). Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell 
growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr 
Cancer, 53(2), 232-243. 
Christen, Y. (2000). Oxidative stress and Alzheimer disease. Am J Clin Nutr, 71(2), 
621S-629S. 
Chrubasik, C., Li, G., & Chrubasik, S. (2010). The clinical effectiveness of chokeberry: 
a systematic review. Phytother Res, 24(8), 1107-1114. 
Cos, P., Ying, L., Calomme, M., Hu, J. P., Cimanga, K., Van Poel, B., Pieters, L., 
Vlietinck, A. J., & Vanden Berghe, D. (1998). Structure-activity relationship 
and classification of flavonoids as inhibitors of xanthine oxidase and superoxide 
scavengers. J Nat Prod, 61(1), 71-76. 
Cossins, E., Lee, R., & Packer, L. (1998). ESR studies of vitamin C regeneration, order 
of reactivity of natural source phytochemical preparations. Biochem Mol Biol 
Int, 45(3), 583-597. 
Dai, J., Gupte, A., Gates, L., & Mumper, R. J. (2009). A comprehensive study of 
anthocyanin-containing extracts from selected blackberry cultivars: extraction 
methods, stability, anticancer properties and mechanisms. Food Chem Toxicol, 
47(4), 837-847. 
Darvesh, A., Carroll, R., Bishayee, A., Geldenhuys, W., & Van der Schyf, C. (2010). 
Oxidative stress and Alzheimer's disease: dietary polyphenols as potential 
therapeutic agents. Expert Rev Neurother, 10(5), 729-745. 
Dauchet, L., & Dallongeville, J. (2008). Fruit and vegetables and cardiovascular 
disease: epidemiological evidence from the non-Western world. Br J Nutr, 
99(2), 219-220. 
Davi, G., Falco, A., & Patrono, C. (2005). Lipid peroxidation in diabetes mellitus. 
Antioxid Redox Signal, 7(1-2), 256-268. 
Davidson, S. M. (2010). Endothelial mitochondria and heart disease. Cardiovasc Res, 
88(1), 58-66. 
de Boer, V. C., Dihal, A. A., van der Woude, H., Arts, I. C., Wolffram, S., Alink, G. 
M., Rietjens, I. M., Keijer, J., & Hollman, P. C. (2005). Tissue distribution of 
quercetin in rats and pigs. J Nutr, 135(7), 1718-1725. 
de Moura, M. B., dos Santos, L. S., & Van Houten, B. (2010). Mitochondrial 
dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen, 
51(5), 391-405. 
 89 
 8
9 
   
   
 
de Pascual-Teresa, S., Moreno, D., & Garca-Viguera, C. (2010). Flavanols and 
anthocyanins in cardiovascular health: a review of current evidence. Int J Mol 
Sci, 11(4), 1679-1703. 
de Whalley, C. V., Rankin, S. M., Hoult, J. R., Jessup, W., & Leake, D. S. (1990). 
Flavonoids inhibit the oxidative modification of low density lipoproteins by 
macrophages. Biochem Pharmacol, 39(11), 1743-1750. 
Dhanasekaran, A., Kotamraju, S., Kalivendi, S. V., Matsunaga, T., Shang, T., Keszler, 
A., Joseph, J., & Kalyanaraman, B. (2004). Supplementation of endothelial cells 
with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial 
iron uptake, oxidative damage, and apoptosis. J Biol Chem, 279(36), 37575-
37587. 
DiMauro, S. (2004). Mitochondrial diseases. Biochim Biophys Acta, 1658(1-2), 80-88. 
Dimauro, S. (2010). A history of mitochondrial diseases. J Inherit Metab Dis, 
34(2):261-76. 
Dragicevic, N., Smith, A., Lin, X., Yuan, F., Copes, N., Delic, V., Tan, J., Cao, C., 
Shytle, R. D., & Bradshaw, P. C. (2011). Green tea epigallocatechin-3-gallate 
(EGCG) and other flavonoids reduce Alzheimer's amyloid-induced 
mitochondrial dysfunction. J Alzheimers Dis, 26(3), 507-521. 
Dubern, B., Broue, P., Dubuisson, C., Cormier-Daire, V., Habes, D., Chardot, C., 
Devictor, D., Munnich, A., & Bernard, O. (2001). Orthotopic liver 
transplantation for mitochondrial respiratory chain disorders: a study of 5 
children. Transplantation, 71(5), 633-637. 
Eichholzer, M., Luthy, J., Gutzwiller, F., & Stahelin, H. B. (2001). The role of folate, 
antioxidant vitamins and other constituents in fruit and vegetables in the 
prevention of cardiovascular disease: the epidemiological evidence. Int J Vitam 
Nutr Res, 71(1), 5-17. 
El Hajji, H., Nkhili, E., Tomao, V., & Dangles, O. (2006). Interactions of quercetin 
with iron and copper ions: complexation and autoxidation. Free Radic Res, 
40(3), 303-320. 
Elingold, I., Isollabella, M. P., Casanova, M. B., Celentano, A. M., Perez, C., Cabrera, 
J. L., Diez, R. A., & Dubin, M. (2008). Mitochondrial toxicity and antioxidant 
activity of a prenylated flavonoid isolated from Dalea elegans. Chem Biol 
Interact, 171(3), 294-305. 
Elliott, A. J., Scheiber, S. A., Thomas, C., & Pardini, R. S. (1992). Inhibition of 
glutathione reductase by flavonoids. A structure-activity study. Biochem 
Pharmacol, 44(8), 1603-1608. 
Estabrook, R. W. (1967). Mitochondrial respiratory control and the polarographic 
measurement of ADP:O ratios. In R. W. Estabrook & M. E. Pullman (Eds.), 
Methods in Enzymology (Vol. 10, pp. 41-47). New York: Academic Press. 
Fiander, H., & Schneider, H. (2000). Dietary ortho phenols that induce glutathione S-
transferase and increase the resistance of cells to hydrogen peroxide are 
potential cancer chemopreventives that act by two mechanisms: the alleviation 
of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Lett, 
156(2), 117-124. 
Filipe, P., Morliere, P., Patterson, L. K., Hug, G. L., Maziere, J. C., Maziere, C., 
Freitas, J. P., Fernandes, A., & Santus, R. (2002). Mechanisms of flavonoid 
 90 
 9
0 
   
   
 
repair reactions with amino acid radicals in models of biological systems: a 
pulse radiolysis study in micelles and human serum albumin. Biochim Biophys 
Acta, 1572(1), 150-162. 
Fink, B. D., O'Malley, Y., Dake, B. L., Ross, N. C., Prisinzano, T. E., & Sivitz, W. I. 
(2009). Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in 
endothelial cells. PLoS One, 4(1), e4250. 
Finkel, T., & Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of 
ageing. Nature, 408(6809), 239-247. 
Fiorani, M., Accorsi, A., & Cantoni, O. (2003). Human red blood cells as a natural 
flavonoid reservoir. Free Radic Res, 37(12), 1331-1338. 
Fiorani, M., Accorsi, A., Blasa, M., Diamantini, G., & Piatti, E. (2006). Flavonoids 
from Italian multifloral honeys reduce the extracellular ferricyanide in human 
red blood cells. J Agric Food Chem, 54(21), 8328-8334. 
Fiorani, M., Guidarelli, A., Blasa, M., Azzolini, C., Candiracci, M., Piatti, E., & 
Cantoni, O. (2010). Mitochondria accumulate large amounts of quercetin: 
prevention of mitochondrial damage and release upon oxidation of the 
extramitochondrial fraction of the flavonoid. J Nutr Biochem, 21(5), 397-404. 
Fiskum, G. (2000). Mitochondrial participation in ischemic and traumatic neural cell 
death. J Neurotrauma, 17(10), 843-855. 
Fraga, C. G., Leibovitz, B. E., & Tappel, A. L. (1988). Lipid peroxidation measured as 
thiobarbituric acid-reactive substances in tissue slices: characterization and 
comparison with homogenates and microsomes. Free Radic Biol Med, 4(3), 
155-161. 
Fridovich, I. (1995). Superoxide radical and superoxide dismutases. Annu Rev 
Biochem, 64, 97-112. 
Galvano, F., La Fauci, L., Lazzarino, G., Fogliano, V., Ritieni, A., Ciappellano, S., 
Battistini, N. C., Tavazzi, B., & Galvano, G. (2004). Cyanidins: metabolism and 
biological properties. J Nutr Biochem, 15(1), 2-11. 
Garcia-Closas, R., Gonzalez, C. A., Agudo, A., & Riboli, E. (1999). Intake of specific 
carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer 
Causes Control, 10(1), 71-75. 
Ghosh, D., & Konishi, T. (2007). Anthocyanins and anthocyanin-rich extracts: role in 
diabetes and eye function. Asia Pac J Clin Nutr, 16(2), 200-208. 
Goyarzu, P., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., 
Moy, E., Moy, D., Lippold, S., Shukitt-Hale, B., & Joseph, J. A. (2004). 
Blueberry supplemented diet: effects on object recognition memory and nuclear 
factor-kappa B levels in aged rats. Nutr Neurosci, 7(2), 75-83. 
Griffiths, L. A. (1982). Mammalian metabolism of flavonoids. In J.Harborne & 
T.Mabry (Eds.), The Flavonoids: Advances in Research (pp. 681-718). London: 
Chapman and Hall. 
Hackett, A. M. (1986). The metabolism of flavonoid compounds in mammals. Prog 
Clin Biol Res, 213, 177-194. 
Halliwell, B., & Chirico, S. (1993). Lipid peroxidation: its mechanism, measurement, 
and significance. Am J Clin Nutr, 57(5 Suppl), 715S-724S; discussion 724S-
725S. 
 91 
 9
1 
   
   
 
Halliwell, B. (1999). Antioxidant defence mechanisms: from the beginning to the end 
(of the beginning). Free Radic Res, 31(4), 261-272. 
Halliwell, B., & Gutteridge, J. M. C. (1999). Free Radicals in Biology and Medicine 
(3rd ed.). Oxford New York: Clarendon Press ; Oxford University Press. 
Halliwell, B. (2001). Role of free radicals in the neurodegenerative diseases: 
therapeutic implications for antioxidant treatment. Drugs Aging, 18(9), 685-
716. 
Halliwell, B. (2006). Reactive species and antioxidants. Redox biology is a 
fundamental theme of aerobic life. Plant Physiol, 141(2), 312-322. 
Halliwell, B. (2011). Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci, 
32(3), 125-130. 
Haraguchi, H., Mochida, Y., Sakai, S., Masuda, H., Tamura, Y., Mizutani, K., Tanaka, 
O., & Chou, W. H. (1996). Protection against oxidative damage by 
dihydroflavonols in Engelhardtia chrysolepis. Biosci Biotechnol Biochem, 
60(6), 945-948. 
Harman, D. (1972). The biologic clock: the mitochondria? J Am Geriatr Soc, 20(4), 
145-147. 
Hassimotto, N. M., Genovese, M. I., & Lajolo, F. M. (2008). Absorption and 
metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from 
wild mulberry (Morus nigra L.) in rats. Nutr Res, 28(3), 198-207. 
Havsteen, B. H. (2002). The biochemistry and medical significance of the flavonoids. 
Pharmacol Ther, 96(2-3), 67-202. 
Heijnen, C. G., Haenen, G. R., van Acker, F. A., van der Vijgh, W. J., & Bast, A. 
(2001). Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. 
Toxicol In Vitro, 15(1), 3-6. 
Heim, K. E., Tagliaferro, A. R., & Bobilya, D. J. (2002). Flavonoid antioxidants: 
chemistry, metabolism and structure-activity relationships. J Nutr Biochem, 
13(10), 572-584. 
Hekimi, S., Lapointe, J., & Wen, Y. (2011). Taking a "good" look at free radicals in the 
aging process. Trends Cell Biol, 21(10), 569-576. 
Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., & Kromhout, D. (1993). 
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen 
Elderly Study. Lancet, 342(8878), 1007-1011. 
Hertog, M. G., Feskens, E. J., & Kromhout, D. (1997). Antioxidant flavonols and 
coronary heart disease risk. Lancet, 349(9053), 699. 
Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010). 
Functional food targeting the regulation of obesity-induced inflammatory 
responses and pathologies. Mediators Inflamm, 2010, 367838. 
Hitchon, C. A., & El-Gabalawy, H. S. (2004). Oxidation in rheumatoid arthritis. 
Arthritis Res Ther, 6(6), 265-278. 
Hodnick, W. F., Duval, D. L., & Pardini, R. S. (1994). Inhibition of mitochondrial 
respiration and cyanide-stimulated generation of reactive oxygen species by 
selected flavonoids. Biochem Pharmacol, 47(3), 573-580. 
Hollman, P. C., & Katan, M. B. (1997). Absorption, metabolism and health effects of 
dietary flavonoids in man. Biomed Pharmacother, 51(8), 305-310. 
 92 
 9
2 
   
   
 
Hollman, P. C., & Katan, M. B. (1998). Bioavailability and health effects of dietary 
flavonols in man. Arch Toxicol Suppl, 20, 237-248. 
Hollman, P. C., & Katan, M. B. (1999). Health effects and bioavailability of dietary 
flavonols. Free Radic Res, 31 Suppl, S75-80. 
Hoye, A. T., Davoren, J. E., Wipf, P., Fink, M. P., & Kagan, V. E. (2008). Targeting 
mitochondria. Acc Chem Res, 41(1), 87-97. 
Hu, J., Huang, Y., Xiong, M., Luo, S., Chen, Y., & Li, Y. (2006). The effects of natural 
flavonoids on lipoxygenase-mediated oxidation of compounds with a benzene 
ring structure-a new possible mechanism of flavonoid anti-chemical 
carcinogenesis and other toxicities. Int J Toxicol, 25(4), 295-301. 
Hyun, J. W., & Chung, H. S. (2004). Cyanidin and malvidin from Oryza sativa cv. 
Heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by 
arrest of G(2)/M phase and induction of apoptosis. J Agric Food Chem, 52(8), 
2213-2217. 
Ichiyanagi, T., Rahman, M. M., Kashiwada, Y., Ikeshiro, Y., Shida, Y., Hatano, Y., 
Matsumoto, H., Hirayama, M., & Konishi, T. (2004a). Absorption and 
metabolism of delphinidin 3-O-beta-D-glucoside in rats. Biofactors, 21(1-4), 
411-413. 
Ichiyanagi, T., Rahman, M. M., Kashiwada, Y., Ikeshiro, Y., Shida, Y., Hatano, Y., 
Matsumoto, H., Hirayama, M., Tsuda, T., & Konishi, T. (2004b). Absorption 
and metabolism of delphinidin 3-O-beta-D-glucopyranoside in rats. Free Radic 
Biol Med, 36(7), 930-937. 
Ichiyanagi, T., Shida, Y., Rahman, M. M., Hatano, Y., Matsumoto, H., Hirayama, M., 
& Konishi, T. (2005). Metabolic pathway of cyanidin 3-O-beta-D-
glucopyranoside in rats. J Agric Food Chem, 53(1), 145-150. 
Ichiyanagi, T., Shida, Y., Rahman, M. M., Hatano, Y., & Konishi, T. (2006). 
Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium 
myrtillus L.) extract in rats. J Agric Food Chem, 54(18), 6578-6587. 
Ioku, K., Tsushida, T., Takei, Y., Nakatani, N., & Terao, J. (1995). Antioxidative 
activity of quercetin and quercetin monoglucosides in solution and phospholipid 
bilayers. Biochim Biophys Acta, 1234(1), 99-104. 
James, A. M., Sharpley, M. S., Manas, A. R., Frerman, F. E., Hirst, J., Smith, R. A., & 
Murphy, M. P. (2007). Interaction of the mitochondria-targeted antioxidant 
MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol 
Chem, 282(20), 14708-14718. 
Johnston, K., Sharp, P., Clifford, M., & Morgan, L. (2005). Dietary polyphenols 
decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett, 579(7), 
1653-1657. 
Joseph, J. A., Denisova, N. A., Arendash, G., Gordon, M., Diamond, D., Shukitt-Hale, 
B., & Morgan, D. (2003). Blueberry supplementation enhances signaling and 
prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci, 
6(3), 153-162. 
Juurlink, B. H., & Paterson, P. G. (1998). Review of oxidative stress in brain and spinal 
cord injury: suggestions for pharmacological and nutritional management 
strategies. J Spinal Cord Med, 21(4), 309-334. 
 93 
 9
3 
   
   
 
Kalt, W., Blumberg, J. B., McDonald, J. E., Vinqvist-Tymchuk, M. R., Fillmore, S. A., 
Graf, B. A., O'Leary, J. M., & Milbury, P. E. (2008). Identification of 
anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food 
Chem, 56(3), 705-712. 
Knekt, P., Jarvinen, R., Reunanen, A., & Maatela, J. (1996). Flavonoid intake and 
coronary mortality in Finland: a cohort study. BMJ, 312(7029), 478-481. 
Knoops, K. T., de Groot, L. C., Kromhout, D., Perrin, A. E., Moreiras-Varela, O., 
Menotti, A., & van Staveren, W. A. (2004). Mediterranean diet, lifestyle 
factors, and 10-year mortality in elderly European men and women: the HALE 
project. JAMA, 292(12), 1433-1439. 
Kong, J. M., Chia, L. S., Goh, N. K., Chia, T. F., & Brouillard, R. (2003). Analysis and 
biological activities of anthocyanins. Phytochemistry, 64(5), 923-933. 
Kowalczyk, E., Krzesinski, P., Kura, M., Szmigiel, B., & Blaszczyk, J. (2003). 
Anthocyanins in medicine. Pol J Pharmacol, 55(5), 699-702. 
Kowaltowski, A. J., & Vercesi, A. E. (1999). Mitochondrial damage induced by 
conditions of oxidative stress. Free Radic Biol Med, 26(3-4), 463-471. 
Krishnaswamy, K., & Raghuramulu, N. (1998). Bioactive phytochemicals with 
emphasis on dietary practices. Indian J Med Res, 108, 167-181. 
Ladiges, W., Wanagat, J., Preston, B., Loeb, L., & Rabinovitch, P. (2010). A 
Mitochondrial view of aging, reactive oxygen species and metastatic cancer. 
Aging cell, 9(4), 462 -465. 
Lagoa, R., Graziani, I., Lopez-Sanchez, C., Garcia-Martinez, V., & Gutierrez-Merino, 
C. (2011). Complex I and cytochrome c are molecular targets of flavonoids that 
inhibit hydrogen peroxide production by mitochondria. Biochim Biophys Acta, 
1807(12), 1562-1572. 
Lapointe, J., & Hekimi, S. (2010). When a theory of aging ages badly. Cell Mol Life 
Sci, 67(1), 1-8. 
Lee, H. C., & Wei, Y. H. (2007). Oxidative stress, mitochondrial DNA mutation, and 
apoptosis in aging. Exp Biol Med (Maywood), 232(5), 592-606. 
Lemanska, K., Szymusiak, H., Tyrakowska, B., Zielinski, R., Soffers, A. E., & 
Rietjens, I. M. (2001). The influence of pH on antioxidant properties and the 
mechanism of antioxidant action of hydroxyflavones. Free Radic Biol Med, 
31(7), 869-881. 
Lippi, G., Franchini, M., Favaloro, E. J., & Targher, G. (2010). Moderate red wine 
consumption and cardiovascular disease risk: beyond the "French paradox". 
Semin Thromb Hemost, 36(1), 59-70. 
Liu, E. H., Qi, L. W., & Li, P. (2010). Structural relationship and binding mechanisms 
of five flavonoids with bovine serum albumin. Molecules, 15(12), 9092-9103. 
Marnett, L. J. (1999). Lipid peroxidation-DNA damage by malondialdehyde. Mutat 
Res, 424(1-2), 83-95. 
Matsumoto, H., Inaba, H., Kishi, M., Tominaga, S., Hirayama, M., & Tsuda, T. (2001). 
Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are 
directly absorbed in rats and humans and appear in the blood as the intact 
forms. J. Agric. Food Chem., 49(3), 1546-1551. 
Matsumoto, H., Ichiyanagi, T., Iida, H., Ito, K., Tsuda, T., Hirayama, M., & Konishi, T. 
(2006a). Ingested delphinidin-3-rutinoside is primarily excreted to urine as the 
 94 
 9
4 
   
   
 
intact form and to bile as the methylated form in rats. J. Agric. Food Chem., 
54(2), 578-582. 
Matsumoto, H., Nakamura, Y., Iida, H., Ito, K., & Ohguro, H. (2006b). Comparative 
assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular 
tissues. Exp. Eye Res., 83(2), 348-356. 
Mattarei, A., Biasutto, L., Marotta, E., De Marchi, U., Sassi, N., Garbisa, S., Zoratti, 
M., & Paradisi, C. (2008). A mitochondriotropic derivative of quercetin: a 
strategy to increase the effectiveness of polyphenols. Chembiochem, 9(16), 
2633-2642. 
Mazza, G., & Brouillard, R. (1987). Recent developments in the stabilization of 
anthocyanins in food products. Food Chem, 25(3), 207-225. 
Mazza, G., Kay, C. D., Cottrell, T., & Holub, B. J. (2002). Absorption of anthocyanins 
from blueberries and serum antioxidant status in human subjects. J Agric Food 
Chem, 50(26), 7731-7737. 
McGhie, T. K., Ainge, G. D., Barnett, L. E., Cooney, J. M., & Jensen, D. J. (2003). 
Anthocyanin glycosides from berry fruit are absorbed and excreted 
unmetabolized by both humans and rats. J Agric Food Chem, 51(16), 4539-
4548. 
McGhie, T. K., & Walton, M. C. (2007). The bioavailability and absorption of 
anthocyanins: towards a better understanding. Mol Nutr Food Res, 51(6), 702-
713. 
Mendes, A., Desgranges, C., Cheze, C., Vercauteren, J., & Freslon, J. L. (2003). 
Vasorelaxant effects of grape polyphenols in rat isolated aorta. Possible 
involvement of a purinergic pathway. Fundam Clin Pharmacol, 17(6), 673-681. 
Mertens-Talcott, S. U., Rios, J., Jilma-Stohlawetz, P., Pacheco-Palencia, L. A., 
Meibohm, B., Talcott, S. T., & Derendorf, H. (2008). Pharmacokinetics of 
anthocyanins and antioxidant effects after the consumption of anthocyanin-rich 
acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J 
Agric Food Chem, 56(17), 7796-7802. 
Mian, E., Curri, S. B., Lietti, A., & Bombardelli, E. (1977). Anthocyanosides and the 
walls of the microvessels: further aspects of the mechanism of action of their 
protective effect in syndromes due to abnormal capillary fragility. Minerva 
Med, 68(52), 3565-3581. 
Middleton, E., Jr., & Kandaswami, C. (1992). Effects of flavonoids on immune and 
inflammatory cell functions. Biochem Pharmacol, 43(6), 1167-1179. 
Middleton, E., Jr., Kandaswami, C., & Theoharides, T. C. (2000). The effects of plant 
flavonoids on mammalian cells: implications for inflammation, heart disease, 
and cancer. Pharmacol Rev, 52(4), 673-751. 
Milagros Rocha, M., & Victor, V. M. (2007). Targeting antioxidants to mitochondria 
and cardiovascular diseases: the effects of mitoquinone. Med Sci Monit, 13(7), 
RA132-145. 
Milam, S. B., Zardeneta, G., & Schmitz, J. P. (1998). Oxidative stress and degenerative 
temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac 
Surg, 56(2), 214-223. 
Miller, D. M., Buettner, G. R., & Aust, S. D. (1990). Transition metals as catalysts of 
"autoxidation" reactions. Free Radic Biol Med, 8(1), 95-108. 
 95 
 9
5 
   
   
 
Mills, S., & Bone, K. (2000). Materia medica. In B. K. Mills S, eds (Ed.), Principles 
and Practice of Phytotherapy (pp. 297-302). New York: Churchill Livingstone. 
Min, S. W., Ryu, S. N., & Kim, D. H. (2010). Anti-inflammatory effects of black rice, 
cyanidin-3-O-beta-D-glycoside, and its metabolites, cyanidin and 
protocatechuic acid. Int Immunopharmacol, 10(8):959-966. 
Miniati, E. (2007). Assessment of phenolic compounds in biological samples. Annali 
dell'Istituto Superiore di Sanità, 43(4), 362-368. 
Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L., Hong, C. P., Nettleton, J. A., 
& Jacobs, D. R., Jr. (2007). Flavonoid intake and cardiovascular disease 
mortality: a prospective study in postmenopausal women. Am J Clin Nutr, 
85(3), 895-909. 
Miyazawa, T., Nakagawa, K., Kudo, M., Muraishi, K., & Someya, K. (1999). Direct 
intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and 
cyanidin-3,5-diglucoside, into rats and humans. J Agric Food Chem, 47(3), 
1083-1091. 
Moon, Y. J., Wang, X., & Morris, M. E. (2006). Dietary flavonoids: effects on 
xenobiotic and carcinogen metabolism. Toxicol In Vitro, 20(2), 187-210. 
Muller-Hocker, J. (1992). Mitochondria and ageing. Brain Pathol, 2(2), 149-158. 
Murphy, M. P., & Smith, R. A. (2007). Targeting antioxidants to mitochondria by 
conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol, 47, 629-656. 
Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochem J, 
417(1), 1-13. 
Nasri, S., Roghani, M., Baluchnejadmojarad, T., Rabani, T., & Balvardi, M. (2011). 
Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-
diabetic rats. Pathophysiology, 18(4), 273-278. 
Neervannan, S. (2006). Preclinical formulations for discovery and toxicology: 
physicochemical challenges. Expert Opinion on Drug Metabolism and 
Toxicology, 2(5), 715-731. 
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, 
S., Cohen, G., Feher, J., Grune, T., Lengyel, G., Mann, G. E., Pamplona, R., 
Poli, G., Portero-Otin, M., Riahi, Y., Salvayre, R., Sasson, S., Serrano, J., 
Shamni, O., Siems, W., Siow, R. C., Wiswedel, I., Zarkovic, K., & Zarkovic, N. 
(2010). Pathological aspects of lipid peroxidation. Free Radic Res, 44(10), 
1125-1171. 
Neto, C. (2007). Cranberry and blueberry: evidence for protective effects against 
cancer and vascular diseases. Mol Nutr Food Res, 51(6), 652-664. 
Newsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L., Procopio, J., Morgan, 
D., Oliveira-Emilio, H. C., Carpinelli, A. R., & Curi, R. (2007). Diabetes 
associated cell stress and dysfunction: role of mitochondrial and non-
mitochondrial ROS production and activity. J Physiol, 583(Pt 1), 9-24. 
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van 
Leeuwen, P. A. (2001). Flavonoids: a review of probable mechanisms of action 
and potential applications. Am J Clin Nutr, 74(4), 418-425. 
Noda, Y., Kaneyuki, T., Mori, A., & Packer, L. (2002). Antioxidant activities of 
pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and 
pelargonidin. J Agric Food Chem, 50(1), 166-171. 
 96 
 9
6 
   
   
 
Nordberg, J., & Arner, E. S. (2001). Reactive oxygen species, antioxidants, and the 
mammalian thioredoxin system. Free Radic Biol Med, 31(11), 1287-1312. 
Noroozi, M., Angerson, W. J., & Lean, M. E. (1998). Effects of flavonoids and vitamin 
C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr, 67(6), 
1210-1218. 
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. 
(2006). Involvement of oxidative stress in Alzheimer disease. J Neuropathol 
Exp Neurol, 65(7), 631-641. 
Obrenovich, M. E., Nair, N. G., Beyaz, A., Aliev, G., & Reddy, V. P. (2010). The role 
of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res, 
13(6), 631-643. 
Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues 
by thiobarbituric acid reaction. Anal Biochem, 95(2), 351-358. 
Oteiza, P. I., Erlejman, A. G., Verstraeten, S. V., Keen, C. L., & Fraga, C. G. (2005). 
Flavonoid-membrane interactions: a protective role of flavonoids at the 
membrane surface? Clin Dev Immunol, 12(1), 19-25. 
Ozawa, T. (1997). Oxidative damage and fragmentation of mitochondrial DNA in 
cellular apoptosis. Biosci Rep, 17(3), 237-250. 
Ozawa, T. (1998). Mitochondrial DNA mutations and age. Ann N Y Acad Sci, 854, 128-
154. 
Page, M. M., Robb, E. L., Salway, K. D., & Stuart, J. A. (2010). Mitochondrial redox 
metabolism: aging, longevity and dietary effects. Mech Ageing Dev, 131(4), 
242-252. 
Passamonti, S., Vrhovsek, U., Vanzo, A., & Mattivi, F. (2005). Fast access of some 
grape pigments to the brain. J Agric Food Chem, 53(18), 7029-7034. 
Passamonti, S., Terdoslavich, M., Franca, R., Vanzo, A., Tramer, F., Braidot, E., 
Petrussa, E., & Vianello, A. (2009). Bioavailability of flavonoids: a review of 
their membrane transport and the function of bilitranslocase in animal and plant 
organisms. Curr Drug Metab, 10(4), 369-394. 
Peluso, M. R. (2006). Flavonoids attenuate cardiovascular disease, inhibit 
phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. 
Exp Biol Med (Maywood), 231(8), 1287-1299. 
Peterside, I. E., Selak, M. A., & Simmons, R. A. (2003). Impaired oxidative 
phosphorylation in hepatic mitochondria in growth-retarded rats. Am J Physiol 
Endocrinol Metab, 285(6), E1258-1266. 
Pieczenik, S. R., & Neustadt, J. (2007). Mitochondrial dysfunction and molecular 
pathways of disease. Exp Mol Pathol, 83(1), 84-92. 
Potter, J. D., & Steinmetz, K. (1996). Vegetables, fruit and phytoestrogens as 
preventive agents. IARC Sci Publ,(139), 61-90. 
Prior, R. L., & Wu, X. (2006). Anthocyanins: structural characteristics that result in 
unique metabolic patterns and biological activities. Free Radic Res, 40(10), 
1014-1028. 
Raha, S., & Robinson, B. H. (2000). Mitochondria, oxygen free radicals, disease and 
ageing. Trends Biochem Sci, 25(10), 502-508. 
Ramirez-Tortosa, C., Andersen, O. M., Gardner, P. T., Morrice, P. C., Wood, S. G., 
Duthie, S. J., Collins, A. R., & Duthie, G. G. (2001). Anthocyanin-rich extract 
 97 
 9
7 
   
   
 
decreases indices of lipid peroxidation and DNA damage in vitamin E-depleted 
rats. Free Radic Biol Med, 31(9), 1033-1037. 
Rando, T. A., Disatnik, M. H., Yu, Y., & Franco, A. (1998). Muscle cells from mdx 
mice have an increased susceptibility to oxidative stress. Neuromuscul Disord, 
8(1), 14-21. 
Ratty, A. K., & Das, N. P. (1988). Effects of flavonoids on nonenzymatic lipid 
peroxidation: structure-activity relationship. Biochem Med Metab Biol, 39(1), 
69-79. 
Reddy, P. H. (2006). Mitochondrial oxidative damage in aging and Alzheimer's 
disease: implications for mitochondrially targeted antioxidant therapeutics. J 
Biomed Biotechnol, 2006(3), 31372. 
Rein, D., Lotito, S., Holt, R. R., Keen, C. L., Schmitz, H. H., & Fraga, C. G. (2000). 
Epicatechin in human plasma: in vivo determination and effect of chocolate 
consumption on plasma oxidation status. J Nutr, 130(8S Suppl), 2109S-2114S. 
Reinboth, M., Wolffram, S., Abraham, G., Ungemach, F. R., & Cermak, R. (2010). 
Oral bioavailability of quercetin from different quercetin glycosides in dogs. J 
Nutr, 104(2), 198-203. 
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996). Structure-antioxidant activity 
relationships of flavonoids and phenolic acids. Free Radic Biol Med, 20(7), 
933-956. 
Richter, C., Park, J. W., & Ames, B. N. (1988). Normal oxidative damage to 
mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A, 85(17), 
6465-6467. 
Rivero-Perez, M. D., Muniz, P., & Gonzalez-Sanjose, M. L. (2008). Contribution of 
anthocyanin fraction to the antioxidant properties of wine. Food Chem Toxicol, 
46(8), 2815-2822. 
Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochem, H. M., Filipovska, A., 
Da Ros, T., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005). Lipophilic 
triphenylphosphonium cations as tools in mitochondrial bioenergetics and free 
radical biology. Biochemistry, 70(2), 222-230. 
Salmon, A. B., Richardson, A., & Perez, V. I. (2010). Update on the oxidative stress 
theory of aging: does oxidative stress play a role in aging or healthy aging? 
Free Radic Biol Med, 48(5), 642-655. 
Santos, A. C., Uyemura, S. A., Lopes, J. L., Bazon, J. N., Mingatto, F. E., & Curti, C. 
(1998). Effect of naturally occurring flavonoids on lipid peroxidation and 
membrane permeability transition in mitochondria. Free Radic Biol Med, 24(9), 
1455-1461. 
Sasaki, R., Nishimura, N., Hoshino, H., Isa, Y., Kadowaki, M., Ichi, T., Tanaka, A., 
Nishiumi, S., Fukuda, I., Ashida, H., Horio, F., & Tsuda, T. (2007). Cyanidin 3-
glucoside ameliorates hyperglycemia and insulin sensitivity due to 
downregulation of retinol binding protein 4 expression in diabetic mice. 
Biochem Pharmacol, 74(11), 1619-1627. 
Scalbert, A., & Williamson, G. (2000). Dietary intake and bioavailability of 
polyphenols. J Nutr, 130(8S Suppl), 2073S-2085S. 
Seddon, M., Looi, Y. H., & Shah, A. M. (2007). Oxidative stress and redox signalling 
in cardiac hypertrophy and heart failure. Heart,93(8), 903-907. 
 98 
 9
8 
   
   
 
Serraino, I., Dugo, L., Dugo, P., Mondello, L., Mazzon, E., Dugo, G., Caputi, A. P., & 
Cuzzocrea, S. (2003). Protective effects of cyanidin-3-O-glucoside from 
blackberry extract against peroxynitrite-induced endothelial dysfunction and 
vascular failure. Life Sci, 73(9), 1097-1114. 
Sheu, S. S., Nauduri, D., & Anders, M. W. (2006). Targeting antioxidants to 
mitochondria: a new therapeutic direction. Biochim Biophys Acta, 1762(2), 256-
265. 
Skulachev, V. P. (1996). Role of uncoupled and non-coupled oxidations in 
maintenance of safely low levels of oxygen and its one-electron reductants. Q 
Rev Biophys, 29(2), 169-202. 
Smith, R. A., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999). Selective 
targeting of an antioxidant to mitochondria. Eur J Biochem, 263(3), 709-716. 
Smith, R. A., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003). Delivery of 
bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A, 100(9), 
5407-5412. 
Smith, R. A., Adlam, V. J., Blaikie, F. H., Manas, A. R., Porteous, C. M., James, A. 
M., Ross, M. F., Logan, A., Cocheme, H. M., Trnka, J., Prime, T. A., 
Abakumova, I., Jones, B. A., Filipovska, A., & Murphy, M. P. (2008). 
Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad 
Sci, 1147, 105-111. 
Soczynska-Kordala, M., Bakowska, A., Oszmianski, J., & Gabrielska, J. (2001). Metal 
ion-flavonoid associations in bilayer phospholipid membranes. Cell Mol Biol 
Lett, 6(2A), 277-281. 
Strobel, P., Allard, C., Perez-Acle, T., Calderon, R., Aldunate, R., & Leighton, F. 
(2005). Myricetin, quercetin and catechin-gallate inhibit glucose uptake in 
isolated rat adipocytes. Biochem J, 386(Pt 3), 471-478. 
Talavéra, S., Felgines, C., Texier, O., Besson, C., Gil-Izquierdo, A., Lamaison, J.-L., & 
Rmsy, C. (2005). Anthocyanin metabolism in rats and their distribution to 
digestive area, kidney, and brain. J Agric Food Chem, 53(10), 3902-3908. 
Tapiero, H., Tew, K. D., Ba, G. N., & Mathe, G. (2002). Polyphenols: do they play a 
role in the prevention of human pathologies? Biomed Pharmacother, 56(4), 
200-207. 
The Parkinson Study Group. (1993). Effects of tocopherol and deprenyl on the 
progression of disability in early Parkinson's disease.The Parkinson Study 
Group. N Engl J Med, 328(3), 176-183. 
The Parkinson Study Group. (1998). Mortality in DATATOP: a multicenter trial in 
early Parkinson's disease. The Parkinson Study Group. Ann Neurol, 43(3), 318-
325. 
Thomasset, S., Berry, D. P., Cai, H., West, K., Marczylo, T. H., Marsden, D., Brown, 
K., Dennison, A., Garcea, G., Miller, A., Hemingway, D., Steward, W. P., & 
Gescher, A. J. (2009a). Pilot study of oral anthocyanins for colorectal cancer 
chemoprevention. Cancer Prev Res, 2(7), 625-633. 
Thomasset, S., Teller, N., Cai, H., Marko, D., Berry, D. P., Steward, W. P., & Gescher, 
A. J. (2009b). Do anthocyanins and anthocyanidins, cancer chemopreventive 
pigments in the diet, merit development as potential drugs? Cancer Chemother 
Pharmacol, 64(1), 201-211. 
 99 
 9
9 
   
   
 
Trumbeckaite, S., Bernatoniene, J., Majiene, D., Jakstas, V., Savickas, A., & Toleikis, 
A. (2006). The effect of flavonoids on rat heart mitochondrial function. Biomed 
Pharmacother, 60(5), 245-248. 
Tsuda, T., Shiga, K., Ohshima, K., Kawakishi, S., & Osawa, T. (1996). Inhibition of 
lipid peroxidation and the active oxygen radical scavenging effect of 
anthocyanin pigments isolated from Phaseolus vulgaris L. Biochem Pharmacol, 
52(7), 1033-1039. 
Tsuda, T., Horio, F., & Osawa, T. (1998). Dietary cyanidin 3-O-beta-D-glucoside 
increases ex vivo oxidation resistance of serum in rats. Lipids, 33(6), 583-588. 
Tsuda, T., Horio, F., Kitoh, J., & Osawa, T. (1999a). Protective effects of dietary 
cyanidin 3-O-beta-D-glucoside on liver ischemia-reperfusion injury in rats. 
Arch Biochem Biophys, 368(2), 361-366. 
Tsuda, T., Horio, F., & Osawa, T. (1999b). Absorption and metabolism of cyanidin 3-
O-beta-D-glucoside in rats. FEBS Lett, 449(2-3), 179-182. 
Tsuda, T., Horio, F., Uchida, K., Aoki, H., & Osawa, T. (2003). Dietary cyanidin 3-O-
beta-D-glucoside-rich purple corn color prevents obesity and ameliorates 
hyperglycemia in mice. J Nutr, 133(7), 2125-2130. 
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006). Free radicals, 
metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 
160(1), 1-40. 
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). 
Free radicals and antioxidants in normal physiological functions and human 
disease. Int J Biochem Cell Biol, 39(1), 44-84. 
van Acker, F. A., Schouten, O., Haenen, G. R., van der Vijgh, W. J., & Bast, A. (2000). 
Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett, 473(2), 
145-148. 
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006). Mechanisms linking obesity 
with cardiovascular disease. Nature, 444(7121), 875-880. 
Varma, S. D., Devamanoharan, P. S., & Morris, S. M. (1995). Prevention of cataracts 
by nutritional and metabolic antioxidants. Crit Rev Food Sci Nutr, 35(1-2), 111-
129. 
Victor, V. M., & Rocha, M. (2007). Targeting antioxidants to mitochondria: a potential 
new therapeutic strategy for cardiovascular diseases. Curr Pharm Des, 13(8), 
845-863. 
Wang, H., Nair, M. G., Strasburg, G. M., Chang, Y. C., Booren, A. M., Gray, J. I., & 
DeWitt, D. L. (1999). Antioxidant and antiinflammatory activities of 
anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod, 62(5), 
802. 
Wei, Y. H. (1998). Oxidative stress and mitochondrial DNA mutations in human aging. 
Proc Soc Exp Biol Med, 217(1), 53-63. 
Wei, Y. H., Ma, Y. S., Lee, H. C., Lee, C. F., & Lu, C. Y. (2001). Mitochondrial theory 
of aging matures--roles of mtDNA mutation and oxidative stress in human 
aging. Zhonghua Yi Xue Za Zhi, 64(5), 259-270. 
Welch, C. R., Wu, Q., & Simon, J. E. (2008). Recent Advances in Anthocyanin 
Analysis and Characterization. Curr Anal Chem, 4(2), 75-101. 
 100 
 1
00
   
   
  
Williams, J. K., & Clarkson, T. B. (1998). Dietary soy isoflavones inhibit in-vivo 
constrictor responses of coronary arteries to collagen-induced platelet 
activation. Coron Artery Dis, 9(11), 759-764. 
Witte, M. E., Geurts, J. J., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010). 
Mitochondrial dysfunction: A potential link between neuroinflammation and 
neurodegeneration? Mitochondrion, 10(5):411-418. 
Wood-Kaczmar, A., Gandhi, S., & Wood, N. W. (2006). Understanding the molecular 
causes of Parkinson's disease. Trends Mol Med, 12(11), 521-528. 
Wu, X., Pittman, H. E., 3rd, McKay, S., & Prior, R. L. (2005). Aglycones and sugar 
moieties alter anthocyanin absorption and metabolism after berry consumption 
in weanling pigs. J Nutr, 135(10), 2417-2424. 
Zamzami, N., Hirsch, T., Dallaporta, B., Petit, P. X., & Kroemer, G. (1997). 
Mitochondrial implication in accidental and programmed cell death: apoptosis 
and necrosis. J Bioenerg Biomembr, 29(2), 185-193. 
Zeviani, M., Bonilla, E., DeVivo, D. C., & DiMauro, S. (1989). Mitochondrial 
diseases. Neurol Clin, 7(1), 123-156. 
Zhang, Y., Marcillat, O., Giulivi, C., Ernster, L., & Davies, K. J. (1990). The oxidative 
inactivation of mitochondrial electron transport chain components and ATPase. 
J Biol Chem, 265(27), 16330-16336. 
Zunino, S. (2009). Type 2 diabetes and glycemic response to grapes or grape products. 
J Nutr, 139(9), 1794S-1800S. 
 
 
 
  
 101 
 1
01
   
   
  
 
Appendix A. Mitochondrial uptake of flavonoids spectrometric method 
 
 
 
 
Figure A.1 Mitochondrial uptake of cyanidin and quercetin. Example tests of 
spectrophotometric measurements. Scan of cyanidin or quercetin (125 µM) in medium 
before and after incubating with RLM and centrifuging.  
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Figure A.2 Resistance of mitochondrial bound/uptaken flavonoids to removal by 
BSA. Percent (%) uptake of flavonoids (125 µM) by RLM (1 mg protein) were 
measured by the spectrophotometric method. Experiments were conducted in 1 mL 
sucrose-HEPES buffer in the presence and absence of a respiratory substrate 
(succinate), and an uncoupler (CCCP) and were compared between with BSA and 
without BSA added before centrifugation.     
Results are expressed as means ± SEM (n=3 mitochondrial preparations), with each 
experiment performed in triplicate. There are no significant differences between with 
BSA and without BSA treatment in measurements of any flavonoids.  
 
 
 
 
 
 
 
 
 
 
 
Control CCCP Succinate Succinate+CCCP
0
30
60
90
BSA-
BSA+
%
 u
pt
ak
e
Control CCCP Succinate Succinate+CCCP
0
5
10
15
%
 u
pt
ak
e
Control CCCP Succinate Succinate+CCCP
0
15
30
45
%
 u
pt
ak
e
Control CCCP Succinate Succinate+CCCP
0
5
10
15
%
 u
pt
ak
e
CY C3G
QU Q3G
 103 
 1
03
   
   
  
Appendix B. HPLC analysis chromatograms and recoveries  
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   Figure B.1. Chromatogram of flavonoids standard solution (60 µM) 
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Figure B.2 HPLC chromatogram of mitochondrial uptake (with BSA). 
Examples chromatograms of extractions from RLM pellet after flavonoids incubation.  
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CY in RLM 
 
 
QU in plasma 
 
 
Figure B.3 HPLC chromatogram of flavonoid in tissues, RLM and plasma. 
Example chromatograms of extractions from tissues, RLM and plasma after 
intravenous administration into rat tail vein to give a dose of 7.6 µmol/Kg body weight 
flavonoids.  
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Table B.1 HPLC analysis parameters and recovery of test flavonoids in tissues, 
plasma and mitochondria. Results are expressed as means ± SEM (n=3 preparations), 
with each experiment performed in triplicate. 
 
Recovery % 
Compound Liver Kidney Brain Heart Plasmas RLM 
( in vivo 
study) 
RLM 
(in vitro 
study) 
CY 33.41 32.88 35.92 25.47 79.33 87.43 92.48 
C3G 26.07 30.36 33.85 22.84 81.28 91.12 86.35 
QU 32.89 34.98 39.63 32.77 80.73 87.94 90.72 
Q3G 28.89 29.02 31.86 30.23 85.27 92.87 93.55 
Compound Limit of detection (µM) Limit of quantification (µM) 
CY 0.3 1.5 
C3G 0.3 1.5 
QU 0.2 1 
Q3G 0.2 1 
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Appendix C. Mass spectrometry analysis of C3G 
15 µM 
 
 
1.5 µM 
 
 
 
Figure C. Chromatogram of mass spectrometry analysis of C3G. During the HPLC 
identification and quantification analysis, we found a shoulder present in the 
chromatogram of C3G. We performed a mass spectrometry analysis on C3G, and 
confirmed it was caused by the presence of isomers. Thus, it would not influence the 
investigation.   
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